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Paediatric Traumatic Brain Injury: The Relationship between Intracranial Pressure 
and Brain Oxygenation 
Abstract 
Introduction: Intracranial pressure (ICP) monitoring is a cornerstone of care for patients with 
severe traumatic brain injury (TBI). The primary goal of ICP treatment is to preserve brain 
oxygenation, and since brain oxygenation is usually not measured, the control of ICP is used 
as a surrogate marker. However studies indicating that cerebral hypoxia/ischemia may occur 
in the face of adequate ICP and cerebral perfusion pressure (CPP) suggest that the interaction 
between ICP and brain oxygenation is poorly understood and warrants further investigation. 
This is of particular importance in the context of children in whom the interpretation of 
relationships between intracranial factors is even more complex due to changing 
physiological norms with age. To date little scientific data exists in children and treatment 
threshold values are often extrapolated from adult guidelines. 
This study aims to better understand the relationship between ICP and brain oxygenation 
measured as brain tissue oxygen tension (PbtO2) in a large paediatric cohort suffering from 
severe TBI. Specifically analysis 1) investigated ICP and PbtO2 profiles over time following 
TBI, 2) examined the relationship between ICP and PbtO2 from time-linked paired 
observations, 3) explored various critical thresholds for ICP and PbtO2, and 4) interrogated 
digital data trends depicting the relationship between ICP and PbtO2. The level of agreement 
between hourly recorded and high frequency electronic data for ICP and PbtO2 was also 
evaluated. 
Method:  Paired ICP and PbtO2 data from 75 children with severe TBI were tested with 
correlation and regression. Additional analyses controlled for mean arterial pressure (MAP), 
arterial partial pressure of oxygen (PaO2), CPP, arterial partial pressure of carbon dioxide 
(PaCO2) and haemoglobin (Hb) using multivariate logistic regression analysis and general 
estimating equations. Various thresholds for ICP were examined; these included age-related 
thresholds to account for the potential influence of age. Receiver-operating curves (ROCs) 
were used to graphically demonstrate the relationships between various thresholds of ICP 
and various definitions of low PbtO2. These were constructed for pooled and individual 
patient data. Interrogation of electronically recorded data allowed for case illustrations 
examining the relationship between ICP and PbtO2 at selected time points. Hourly and 
electronic data were compared using Bland and Altman plots and by contrasting the 












 Result: Analyses using over 8300 hours of paired observations revealed a weak relationship 
between ICP and PbtO2, with an initially positive but weak slope (r = 0.05) that trended 
downwards only at higher values of ICP. Controlling for inter-individual differences, as well 
as MAP, CPP, PaO2, PaCO2 and Hb did not strengthen this association. This poor 
relationship was further reflected in the examination of threshold ICP values with ROCs, no 
singular critical ICP threshold for compromised brain oxygenation was discernible. Using 
age-based thresholds did not improve this relationship and individual patient ROCs 
demonstrated inter-individual heterogeneity in the relationship between ICP and PbtO2. 
However, it was clear that in individual patients ICP did exhibit a strong negative 
relationship with PbtO2 at particular time points, but various different relationships between 
the 2 variables were also demonstrated. A high level of agreement was found between hourly 
and electronic data. 
Conclusion: These results suggest that the relationship between ICP and PbtO2 is highly 
complex. Although the relationship in individual children at specific time points may be 
strong, pooled data for the entire cohort of patients, and even for individual patients, suggest 
only a weak relationship. This is likely because several other factors affect PbtO2 outside of 
ICP, and some factors affect both independently of each other. These results suggest that 
more study should be directed at optimising ICP thresholds for treatment in children. The use 
of complimentary monitoring modalities may assist in this task. Depending on the adequacy 
of measures of brain perfusion, metabolism or oxygenation, it is possible that targeting a 
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Traumatic brain injury (TBI) is a major contributor to the burden of disease in children and 
adults worldwide 
82, 98, 110
. In the United States (US) injury is the leading cause of death in 
patients from ages 1 to 34 years 
9, 116
 and accounts for more than two thirds of deaths in 
children between the ages of 5 and 19 years 
1
, with nearly 3000 children dying of TBI each 
year 
33
. In developing countries the impact of TBI is more concerning; in South Africa for 
example, injury remains the leading cause of death in children over the age of 4 years 
15
, and 
the chances of dying due to injury in childhood is 6 times greater than in the Unites States 
15, 
77
. Of all injured children, the highest risk of death and permanent disability occurs in those 




Mortality rates reported in paediatric studies of TBI range from 20-30%. Many of these 
deaths are potentially preventable 
38
 and the high incidence of death and neurological 
disability associated with TBI may be attenuated by effective medical care. Early access to 
efficient emergency care alone may decrease paediatric deaths by as much as 30% 
22
 and 
improved outcome is associated with more vigorous in-hospital management 
125, 136
. Most of 
this treatment is directed at preventing or ameliorating secondary insults associated with 
TBI.  
Severe TBI has a significant impact on the lives of those children affected, not only in terms 
of the high mortality, but also because of the potential for permanent neurological, physical 
and cognitive disability in survivors. TBI presents many challenges for the child affected, 
their family, schools and society at large. Children who have incurred an injury to the head 
may experience considerable cognitive and behavioural deficits which have far reaching 
consequences and may persist for life. Memory impairment, learning difficulties, speech and 
communication difficulties are among the most common cognitive impairments and 
behavioural problems associated with poor control over negative emotions may also arise 
112
. 












specialized education and rehabilitation programs, which would ideally provide for the 
education and support needs of the family as well 
112
. Currently the economics of health care 
render such services limited, and poor outcome associated with TBI continues to have 
significant economic implications on the health care system. TBI accounts for an annual 
incidence of hospitalisation of 85 per 100 000 and 235 per 100 000 in the US and Europe 
respectively, it poses one of the largest financial burdens on medical expenses and the 
indirect costs of years of life lost due to disability and death are great 
82, 109, 118, 130
.  
Demographic Profiles of Paediatric TBI 
Boys sustain TBI more commonly than girls. The mechanism of injury differs according to 
age and economic background and is associated with different levels of injury severity and 
pathology 
47
.  Mild TBI is often the result of minor falls, whereas severe TBI is more 
commonly caused by falls from a significant height and motor vehicle accidents (MVA). 
Severe TBI in infants is often inflicted, associated with severe diffuse injury and a high 
prevalence of ischemic injury due to a delay in treatment. Falls are the most common cause 
of TBI among toddlers, while older children are more likely to incur injury through MVA’s. 
Diffuse injury is common in children, with focal contusions and haematomas seen less 
frequently than in the adult population 
47
.  
Studies investigating paediatric TBI differ in terms of the age range with which they define 
childhood 
26, 52, 67, 111, 131
 with some studies including patients up to the age of 18 -21 years 
25, 
52
. Age range is an important consideration when studying a paediatric population as children 
of differing ages display variation in their physiology, their vulnerability and sensitivity to 
injury, and their recovery trajectories. Age-related differences exist in intracranial pressure 
(ICP) and blood pressure (BP) norms within the pediatric population, with normal values of 
ICP and BP rising with age 
27, 115
. Mortality is highest in the very young, decreasing till the 
age of 12, after which it begins to rise again 
27
. The physiological makeup of adolescents 
may also have greater similarity to adults than is the case for younger children. This has 
significant bearing on treatment thresholds and the extent to which these management 
guidelines should be extrapolated from adult values. This dissertation employs a paediatric 
age range from 0-14 years. 
Assessing children in comparison to adults 
Children are different to adults in several important aspects relevant to TBI. Children and 
adults are vulnerable to different kinds of injury mechanisms, injury type and biomechanics. 












cerebral blood flow (CBF) and ICP, as well as differences in pressure-volume intracranial 
dynamics and possibly autoregulatory mechanisms. The pathophysiological cascade 
following TBI may vary significantly with age, and consequently also the mode of optimal 
treatment.  For example, medications like anticonvulsants may have unique effects on the 
immature nervous system, and measures such as decompressive craniectomies (DC) may 
have more beneficial outcomes in the paediatric population 
 47
. The extrapolation of 
treatment guidelines from adult research is therefore not entirely appropriate, but often 
occurs because of the lack of data for the paediatric population. While the developing brain 
may hold the advantage of greater plasticity, it is also apparent that it is simultaneously more 
vulnerable to injury. Consequently, children may differ significantly in their recovery 

















SECONDARY INJURY: CEREBRAL ISCHEMIA 
 
Primary and Secondary Injury 
Primary injury following TBI involves the cerebral tissue damage that occurs at the moment 
of injury. Little can be done to amend this damage by medical intervention, and 
consequently the window of opportunity lies in the time following the trauma as attempts are 
made to avoid and ameliorate secondary injury. 
Secondary injury is the delayed loss of viable tissue attributable to events set in motion at the 
time of primary injury or its aftermath. Secondary brain injury plays a major role in 
determining outcome after TBI, and avoidable factors may contribute to as much as 42% of 
TBI deaths in children 
37, 118
. Secondary insults associated with TBI may manifest in terms of 
intracranial dynamics, like intracranial hypertension and seizures, systemic dynamics 
including hypotension and hypoxia, as well as cellular dynamics, including mitochondrial 
dysfunction, neurotransmitter release and cell damage 
82
. Understanding and treating these 
secondary insults appropriately is crucial as timely intervention may improve outcome.  
Cerebral Ischemia/ Hypoxia 
The mechanisms of secondary injury are diverse, however the final common pathway is 
often cerebral ischemia 
139
. Cerebral ischemia is a common and potentially devastating 
secondary injury following TBI. It represents a major cause of mortality and morbidity in 
these patients and post-mortem studies suggest that more than 90% of patients who die due 
to TBI have evidence of cerebral ischemic damage 
49
. Prompt detection and treatment of 
ischemia may minimize the potential for irreversible brain damage 
55
. 
Adequate oxygenation of the brain depends on several factors, including sufficient systemic 
oxygen delivery, perfusion of the brain, and diffusion of oxygen through the tissues. There 
are several physiological factors that in turn affect each of these parameters. 
Cerebral blood flow 






. Under normal 
circumstances CBF and cerebral metabolism are tightly coupled. Normal values of CBF 




















. A reduction of CBF levels below this 
critical threshold is associated with corresponding changes in cerebral metabolism 
119
 
including progressive electrical failure, EEG flattening, as well as cellular acidosis and net 
energy loss resulting from an imbalance of increasing glycolysis and limited oxidative 
phosphorylation. Further decreases in CBF result in membrane failure, and ultimately 
infarction, as CBF falls below 10 ml/100g/min 
90
. The extent of ischemic damage is 
dependent on both the depth and duration of tissue hypoxia. 
However, in the head-injured patient the relationship between CBF and metabolism is more 
complex. Lower levels of CBF may not necessarily equate to ischemia and may be 
appropriate for injured tissue that has reduced metabolic needs and/or mitochondrial 
dysfunction. Conversely, supposedly normal levels of CBF may not be adequate where there 
is increased metabolic demand if there is uncoupling between CBF and cerebral metabolism. 
Metabolic needs after head injury, mitochondrial dysfunction, level of oxygen extraction and 
coupling between metabolism and CBF must therefore be taken into account to correctly 
interpret absolute values of CBF 
32
. 
Cerebral perfusion pressure  
CBF depends on several factors, including cerebral perfusion pressure (CPP). CPP plays an 
important role in the pathophysiological cascade leading up to ischemia; first, it represents 
the pressure gradient across the cerebrovascular bed and is therefore an important regulator 
of CBF, and second, CPP contributes to the intravascular hydrostatic pressure, and can be an 
important determinant of oedema formation 
55
. When CPP is reduced below the lower 
threshold of autoregulation (40-50mm Hg), CBF proportionately decreases as the 




 potentiating the development of cerebral 
ischemia, depending on the duration of the insult.  
CPP is the difference between mean arterial pressure (MAP) and ICP (CPP = MAP – ICP), 
and therefore, reductions in CPP are seen either due to decreased MAP or increased ICP, 
however it is suggested that the former has the greater negative effect 
55
. CPP is largely 
dependent on the status of cerebral pressure autoregulation, and consequently has 
implications for ICP and brain oxygenation management. 
Ensuring adequate brain perfusion is important in attempting to prevent ischemic episodes, 
however setting an optimal CPP is a matter of debate in both adult and child health care. In 
children the task is further complicated by age-related variation in BP and autoregulation 













26, 28, 52, 67, 101, 142
. Perhaps ideally CPP management should be tailored to the 
physiological, pathological and age profile of the individual patient but there is little data to 
support this as yet.  
Pressure Autoregulation 
Normal cerebral functioning is highly dependent on the maintenance of constant CBF. The 
impact of fluctuations in MAP on cerebral perfusion is therefore tightly controlled by 
pressure autoregulation and the vascular reactivity of cerebral resistance vessels (arterioles of 
approximately 200 micron in diameter) 
72
.  
When pressure autoregulation is intact, an increase in MAP within the autoregulatory range 
will result in cerebral vasoconstriction and maintenance of a relatively constant CBF. 
Conversely, cerebral vessels respond to a drop in MAP by vasodilatation allowing for 
increased flow. However, when pressure autoregulation is impaired cerebral vessels fail to 
adjust their calibre to changes in MAP and passively distend with increased blood pressures, 
causing increased CBV and therefore increased ICP. Clinically, the changes in ICP in 
response to a change in blood pressure may be helpful as a surrogate marker of the status of 
autoregulation 
124
 .  
Oxygen diffusion through tissues 
In addition to limited perfusion, structural mechanisms relating to tissue damage may also 
cause cerebral ischemia. Transport of oxygen from the vessels into tissues takes place 
through diffusion, driven by partial pressure gradients. Consequently, increases in the 
diffusion distance of oxygen between the vessels and tissues may reduce intracellular oxygen 
tension and potentiate ischemia. Factors associated with TBI which may increase the 
diffusion distance include cytotoxic cell swelling, perivascular oedema, collapsed capillaries 
and arteriovenous shunting 
92
. 
Managing secondary injury 
TBI management focussed on averting secondary ischemic injury therefore must ensure that 
CBF and oxygenation are sufficient to meet cerebral metabolic needs. The 
pathophysiological cascade following TBI is complex, and this treatment end point involves 
managing the interplay of a number of relevant variables; ICP and brain oxygenation are 












Detecting secondary injury, or predicting which patients are at risk of developing secondary 
injury, remains a major challenge. Clinical assessment of neurological function can be 
challenging in patients who are sedated and artificially ventilated, currently used biomarkers 
of brain injury do not have sufficient sensitivity and specificity to warrant routine use to 
guide TBI care, and imaging of the brain does not necessarily predict who is at risk for 
secondary injury. Due to the limitations of these modalities, there has been increased interest 
in technologies that are able to monitor brain physiology and function continuously in the 
acute phase after TBI. 
ICP and CPP monitoring have become a cornerstone of TBI care. Positron emission 
tomography (PET) imaging is currently the gold standard for detecting cerebral ischemia; 
however, these studies are primarily research tools, require stable patients, and can only 
determine the prevalence of ischemia at one point in time, whereas TBI is a dynamic 
pathophysiological process. Recent technology in the form of brain tissue oxygen tension 
(PbtO2) monitoring has allowed for a more direct means of assessing brain oxygenation and 
is being used increasingly in the management of patients with severe TBI 

















ICP is elevated in 30-80% of head injured patients 
105, 117
. Uncontrolled ICP is associated 
with considerable risk of herniation and brain ischemia, and is considered the major 
contributor to hospital death due to head injury 
102
. 
Intracranial pressure physiology 
According to the Monroe-Kellie doctrine the intracranial compartments coexist in a 
reciprocal manner, whereby small increases in the volume of any of the components can be 
offset by an equal, compensatory decrease in cerebrospinal fluid (CSF) volume and cerebral 
blood volume. This compliance allows for change in the intracranial volume which reflects 
only minimally on ICP. The cerebral compensatory reserve is however limited, and when the 
compensatory capacity is exhausted, any additional increases in intracranial volume may 
lead to a precipitous increase in ICP (Figure 1). This is reflected in the hyperbolic nature of 
the cranial pressure – volume relationship 
108
, with compliance being represented by change 
in volume /change in pressure. The nature of the pressure-volume curve may however 
demonstrate differences across time and across individual patients. 
 
Figure 1: A graphic illustration of the pressure-volume curve of the brain. When compliance is greater (A), a 
given change in volume (∆VA) produces minimal change in ICP (∆PA). However, when compliance is decreased 












Factors affecting ICP 
Several cerebral hemodynamic and regulatory mechanisms have important relationships with 
ICP. Blood pressure has a complex interaction with ICP. When pressure autoregulation is 
preserved, increasing BP within the normal autoregulatory range leads to active 
vasoconstriction of arterioles and an overall reduction in CBV, which leads to a slight 
decrease in ICP 
45
. However, when autoregulation is impaired, increased BP passively 
distends the cerebral vessels causing increased CBV and ICP 
13, 74
. The increase in BP may 
also increase intracapillary hydrostatic pressure, and potentially aggravate vasogenic 
oedema.  
CO2 reactivity exerts a significant influence on ICP based on its effect on vascular tone and 
blood volume, whereby higher CO2 values are associated with vasodilation and hence 
increased ICP, and lower values with the reverse. Hyperventilation is therefore a commonly 
used and effective means of treating raised ICP, albeit with an increased risk of ischemia 
97
. 
CBF and cerebral metabolism normally exhibit close coupling. In this way metabolic 
suppression may reduce ICP by reducing CBF, if coupling between CBF and metabolism is 
intact. 
Intracranial hypertension following TBI 
Raised ICP after TBI is an important manifestation of underlying physiological perturbations 
which may result in potentially dangerous changes to intracranial volume. These include; 1) 
traumatic hematomas in the intracerebral, subarachnoid, subdural or extradural spaces that 
may result in brain shifts, 2) cerebral oedema which contributes increased water to the 
intracranial volume due to cytotoxic or vasogenic mechanisms 
88
, and 3) changes in CBV as 
a result of impaired pressure autoregulation and the uncoupling between CBF and 
metabolism which may potentiate vascular congestion. Of note, hyperaemia was long 
thought to be a common cause of raised ICP in paediatric TBI, but is now considered to be 
less so 
19, 148
. Post-traumatic hydrocephalus is less frequently encountered. 
Consequences of raised ICP  
Raised ICP may compromise brain oxygenation and cause herniation due to pressure 
gradients created within the cranial cavity 
76, 144
. Brain oxygenation decreases as cerebral 
perfusion compromise leads to progressively reduced CBF and subsequent metabolic 












Herniation is usually seen only with very high values of ICP, but may also occur at lower 
elevations of ICP than would be expected. Still, it is generally the adverse effects of ICP on 
brain perfusion and brain oxygenation that are of usual concern during ongoing patient 
management in the typical range of increased ICP managed in the ICU. The purpose of 
controlling ICP is therefore to ensure adequate CPP and CBF, thereby ensuring sufficient 
brain oxygenation and metabolic substrate delivery, while avoiding herniation 
3, 64
. 
Time course of raised ICP 
The time course of ICP after TBI is variable, and may be a function of the underlying cause 
of increased ICP. Intracranial hypertension may often develop in the acute stages following 
TBI due to haematomas, but may also have delayed onset due to progressive brain oedema 
71, 
98, 135
. In a study by Stocchetti et al 
128
 mean ICP rose progressively in the days following 
TBI, suggesting that continued monitoring is indicated by the continued occurrence of high 
ICP. In their cohort as much as 20% of patients demonstrated their highest mean ICP after 
Day 5. These findings are mirrored by those of Unterberg et al 
 135
 who found delayed onset 
of intracranial hypertension in 31% of their patients, and O’Phelan et al 
98
 who found 
delayed ICP rise in 17% of their patients. However, all of these studies demonstrated the 
majority of ICP peaks early, within the first 72 hours, and suggest that delayed elevation in 
ICP may be attributable to delayed intracranial haemorrhage or delayed cerebral oedema 
surrounding contusions. The temporal heterogeneity in ICP also highlights intra- and inter-
individual variability in TBI.  
Methods of ICP monitoring 
The external ventricular drain (EVD) is considered the gold standard for measuring ICP. It is 
associated with a low risk of infection and is thought to be the most accurate, inexpensive 
and reliable method. Intraparenchymal fibreoptic and electronic strain gauge systems are 
being used more frequently, especially where insertion of an EVD is complicated by small 
ventricle size. Subdural and extradural monitors may also be used although they are much 




. Common to all of these parenchymal 
monitors is the issue of zero and sensitivity drift, which reduces the accuracy over time. 
However, most current monitors in use have relatively low rates of measurement drift. 
The most common complications associated with ICP monitor insertion are haemorrhage, 
infection and device malfunction. In general the risk of these complications remains low 
100
, 
however the incidence may vary depending on the device used, the duration of monitoring 















Evidence indicates that raised ICP is associated with poor neurological outcome and 
increased mortality in children 
3, 21, 25, 26, 64, 100, 110
. Although the evidence base for directing 
ICP monitoring and treatment in children is small it is clear that ICP monitoring and 
aggressive treatment to control intracranial hypertension are associated with improved 
clinical outcome 
3, 39, 110
. The indications for ICP monitoring are however not well defined 
and current recommendations are extrapolated from adult guidelines 
 3
. Currently there is 
also only one set of international guidelines for treating ICP in severe paediatric TBI, 
however the poor quality of evidence available for establishing these guidelines has been 
highlighted by the authors 
2, 6
. The currently recommended ICP treatment threshold for 
children is 20 mmHg 
4, 93
.  
As yet no age-related threshold recommendations have been established, and none are 
recommended in the current guidelines, but a study conducted in paediatric ICU’s across the 
United Kingdom found that most treating clinicians attempted to take account of age when 
setting ICP thresholds, although strategies were variable due to the lack of standard 
recommendations 
115
. This finding is confirmed by a study of physician agreement on ICP 
treatment protocols, in which physician practice portrayed the greatest discrepancy with 
respect to age appropriate ICP thresholds 
33
. It is apparent that international guidelines 
incorporating the unique physiological and pathophysiological profiles of children are 
needed, and would be of tremendous benefit in the treatment of these patients. To date there 



















Several techniques are available for monitoring various aspects of brain oxygenation, 
including ‘snapshot’ imaging of the brain, and continuous methods such as jugular venous 
bulb saturation (SjvO2), brain tissue oxygen tension (PbtO2) and near-infrared spectroscopy. 
These continuous monitors differ in the physiological variables they measure and the 
physical principles used to measure them. Arguably,  PbtO2 appears to capture regional 





, and has tended to be favoured in the recent literature on neurocritical care 
management of TBI, subarachnoid haemorrhage, meningitis, and during cerebral surgery 
24, 
46, 62, 65, 69, 75
. It is considered to be a useful guide to clinical management 
16, 41, 43, 44, 75, 107, 125
 
and a tool by which to explore the mechanisms of tissue oxygenation in the injured brain 
92, 
107
. A phase II trial is currently being planned in preparation for a Phase III randomised 
control trial assessing the effect of PbtO2 monitoring in severe TBI management. 
Defining PbtO2  
The matter of defining what exactly PbtO2 monitors measure is debated. It has been 
suggested that PbtO2 represents the balance between cerebral oxygen supply and demand, 
that it is associated with CBF 
63, 137
, that it represents the product of blood flow and 
arteriovenous difference in oxygen tension 
107
, and that it is associated with the mean transit 
time of blood through the brain 
53
, arteriovenous difference of oxygen, and end-capillary 
venous PO2 
43, 51, 107, 113
. This uncertainty may result from the fact that the specific 
determinants of PbtO2 are not yet well indentified, and aspects of oxygen diffusion in brain 
tissue are only beginning to be elucidated 
92
. However, PbtO2 is probably best considered as 
a measure of the factors that affect both the perfusion and diffusion characteristics of oxygen 
in brain tissue. 
Factors influencing PbtO2 
Understanding the role of PbtO2 in the pathophysiology of TBI rests heavily on the 
appreciation that PbtO2 is a highly dynamic variable, significantly affected by a number of 
factors.  A systemic factor which has a particularly important association with PbtO2 is the 












oxygen in brain tissue. Therefore, even if blood is near full saturation, an increase in PaO2 
will lead to an increase in PbtO2 although this may not necessarily reflect substantial 
changes in oxygen delivery or in cerebral metabolic rate of oxygen 
107
. On the other hand, 
even when substantial changes to oxygen content have not occurred, higher partial pressures 
of oxygen may increase the gradient of oxygen diffusion into tissues. This may overcome 
barriers to diffusion resulting from tissue damage and oedema, which may increase the 
diffusion distance of oxygen
92
, and in so doing improve metabolism 
35, 83, 95, 132
.  Arterial 
PCO2 may also influence PbtO2 as a consequence of the vasoreactive effects of PaCO2, if 
CO2 reactivity is preserved 
50, 60, 85, 114
. Hypocarbia may lead to decreases in PbtO2 mediated 
by decreases in CBF, and hypercarbia may cause a rise in PbtO2 accompanied by an increase 
in CBF. On the other hand, very high levels of PaCO2 can also result in a substantial drop in 
PbtO2 as a marked increase in CBF may result in substantially increased CBV and 
subsequently ICP. Along with the different responses to CO2 in injured versus non-injured 
tissue, this may account for occasional ‘paradox’ reactions of PbtO2 to altered PaCO2 
50
. 
Studies that have examined the relationship between PbtO2 and CPP have shown conflicting 
results 
8, 20, 31, 34, 66, 86, 104, 127, 134, 143
. While induced hypertension is usually associated with 
increased PbtO2, variability in PbtO2 responses may occur partly because of differences in 
the strength of autoregulation between patients. Increased ICP may cause a decrease in 
PbtO2 due to a local tissue pressure effect or by a reduction in CPP. However, the overall 
relationship between ICP and PbtO2 is variable because several other factors affect PbtO2 
44
. 
The relationship between ICP and PbtO2 will be discussed in greater detail in the following 
chapter. 
Interpreting PbtO2 measurements 
Normal and threshold values have not been established in healthy humans; however, animal 
studies demonstrating normal values in the region of 25-30 mmHg have been confirmed in 
patients with normal ICP and CPP, in normal tissue in patients with brain tumours, and in 
patients who underwent temporary clipping of cerebral vessels 
34, 36, 57, 68, 70, 75, 81
. 
PbtO2 and outcome 
Poor outcome following TBI has been shown to have a higher likelihood when PbtO2 levels 
fall progressively below 20 mmHg 
136
, reductions of less than 10 mmHg are typically 
associated with ischemic injury 
113, 126
 and a threshold of PbtO2 = 10mmHg appears to have 
the strongest association with outcome 
16, 43, 75, 143
. Increased frequency, depth and duration of 
cerebral hypoxia are associated with poorer outcome 
16, 29, 43, 126, 136, 138












between 15 and 20 mmHg may act as an early warning sign for oligemia or cell damage 
43
. 
PbtO2 levels less than 10 mmHg have been associated with classic ischemic CBF thresholds, 
jugular venous desaturation, perturbations in microdialysis parameters, decreased 
mitochondrial function and impaired neuronal activity 
50, 54, 58, 113, 137
. Low PbtO2 values have 
been shown to be independent and strong prognosticators of poor outcome and death after 
adult and paediatric head trauma 
43, 138
.  In the largest study of paediatric TBI, PbtO2 was an 
independent factor associated with poor outcome, and a stronger predictor than other factors 
traditionally associated with outcome 
43
. Furthermore, low PbtO2 was shown to be poorly 





Low PbtO2 values occur most commonly in the first 24 hours post-injury 
29, 126, 138, 138
, and 
correspond to lower CBF, increased lactate and cellular acidosis during this period 
14, 30
. 
While low levels of PbtO2 may occur at any time during the acute phase, initially low PbtO2 
appears to stabilize within 24 to 48 hours 
141
. 
Methods of brain oxygenation monitoring 
Three systems of measuring brain tissue oxygen tension have been developed commercially, 
the Licox (Integra Neurosciences, Plainsboro, NJ), the Neurotrend (Codman, Raynham, MA) 
which is no longer in use, and the newer Neurovent (Raumedic, Munchberg, Germany). The 
Licox is the current gold standard in PbtO2 measurement, and is used at our institution. It 
functions as a Clarke-type electrochemical probe composed of 2 metal coated electrodes 
placed in an oxygen permeable electrically insulating membrane. As they pass through the 
membrane oxygen molecules undergo reduction at the site of the measuring electrode, and 
the partial pressure of oxygen can therefore be measured by the voltage difference generated 
between the reference and measuring electrodes 
120
. Complications associated with probe 
insertion are rare, and tissue damage is minimal 
75
. The sampling area is approximately 13-
14 mm²  
59, 75, 103
, considering that cerebral oxygen distribution may demonstrate significant 
spatial heterogeneity, this small penetration depth does limit the generalizability of probe 
readings, making this a more focal monitor. 
The Neurovent is an optical probe which works on a different principle of dynamic 
luminescence quenching.  On contact with oxygen molecules, the luminescent light emitted 
from a luminophore encapsulated in an oxygen permeable membrane is attenuated and the 












calculated based on the relationship between the tissue oxygen concentration and the 
luminescence intensity and lifetime 
59, 120
. The oxygen sensitive sampling area is 
approximately 22 mm²  
59, 103
 and the probe combines PbtO2 with ICP and brain temperature. 
While evidence suggests that the Neurotrend performs similarly to the Licox 
59, 103
, further 
research would be valuable in validating this new technique. 
Managing PbtO2 
SjvO2 and PbtO2 monitoring have been included in the Brain Trauma Foundation’s 
guidelines for brain oxygenation monitoring for the first time at the level of an option that 
SjvO2 < 50% and PbtO2 < 15 mmHg represent treatment thresholds 
16
. Due to a paucity of 
research in this field, no formal treatment guidelines are outlined for paediatric TBI. In 
adults however the currently used treatment threshold in many centres is 20 mmHg 
84
, but 




While it is clear that low PbtO2 is associated with poorer outcome 
16, 43, 125, 136, 138
, the issue of 
whether treatment directed by PbtO2 monitoring improves outcome needs further 
clarification, similar to all other monitors including ICP. Stiefel et al 
125
 compared PbtO2 
directed-therapy with ICP-directed therapy and found that PbtO2-directed therapy led to a 
significant decrease in mortality. In a cohort of 139 patients with TBI Narotam et al 
94
 also 
reported decreased mortality associated with PbtO2 monitoring as well as significantly 
improved clinical outcomes in comparison to standard ICP/CPP-directed treatment. On the 
other hand, one study suggested that PbtO2-directed therapy did not benefit patients 
91
. The 
finding of this study may however be limited by the fact that the indication for PbtO2 
monitoring was not controlled and therefore the patient groups were not equal. Further study 
is required for Class I evidence demonstrating the benefit of PbtO2 monitoring. As in the 
case of ICP monitoring, a randomized trial of PbtO2 monitoring is needed. Clinical trials to 
compare ICP and PbtO2-directed treatment are in preparation. 
Monitoring PbtO2 
It is worth highlighting that PbtO2 is a focal monitor, and therefore careful thought should be 
given to placement of the catheter. Although ‘normal’ tissue may not display the 
perturbations of tissue at higher risk of ischemic injury, peri-contusional or peri-lesional 
tissue may exhibit abnormal physiology and responses to interventions that may not reflect 
the responses of the rest of the brain 
34, 50, 66











Children’s Hospital is to place the catheter in right frontal white matter when there is diffuse 
injury, on the affected side of a more injured hemisphere, and in the normal-appearing tissue 
surrounding the contusion in the case of focal injury. There is much discussion about to what 
degree focally measured PbtO2 can be extrapolated to reflect a more global assessment of 
brain oxygenation. Significant spatial heterogeneity may limit the usefulness of data 
obtained from a single location. Additionally, because PbtO2 is not an ‘ischemia monitor’ 
per se 
96
, other factors that influence PbtO2, such as diffusion through tissues, must be 
considered in the interpretation of results.  
Currently there are no formal guidelines detailing indications for PbtO2 monitoring in either 













THE RELATIONSHIP BETWEEN INTRACRANIAL PRESSURE 
AND BRAIN OXYGENATION 
 
The relationship between intracranial hypertension and brain oxygenation 
Elevated ICP may compromise brain oxygenation in several ways. First, elevated ICP 
reduces CPP and thereby may compromise blood flow and oxygen delivery to the brain, 
depending on the presence of autoregulation and the absolute reduction in CPP. Second, high 
ICP may exert a tissue pressure effect which may further compromise tissue perfusion and 
oxygen diffusion into cells.  
Physiologically, raised ICP and impaired brain oxygenation are related, in the absence of 
other influencing factors. The evidence base indicating the association between high ICP and 
poor outcome is extensive 
17, 87, 89
. Many studies have also shown low brain oxygenation to 
be associated with ischemia, infarction and poor outcome 
43, 126, 136, 138
. Patients who die after 
sustaining TBI often have evidence of both high ICP and brain ischemia. Therefore, a 
primary reason for treating ICP is to ensure adequate brain perfusion and prevent cerebral 
ischemia. However, several studies have shown that ischemic brain damage may occur 
despite adequate CPP and ICP. A summary of a number of studies investigating the 
relationship between ICP and PbtO2 are outlined below. To date, none have investigated this 
in children. 
Investigating ICP and brain oxygenation  
In a study on the prevalence of brain hypoxia and its relationship to ICP in adult TBI, Chang 
et al 
29
 found that hypoxic episodes occurred mostly in the context of normal ICP and only 
23% occurred concurrently with episodes of ICP > 20 mmHg. Brain hypoxia exhibited a 
stronger association with CPP < 70 mmHg. On the other hand, Le Roux et al 
79
 found that 
elevated arteriovenous difference of oxygen was not significantly related to CPP. These 
results indicate that ischemia/ hypoxia may also occur despite apparently adequate levels of 
CPP and that this may be explained by other factors such as disturbed autoregulation. 
Stiefel et al 
126
 assessed the role of adequate ICP and CPP in ensuring acceptable cerebral 
oxygenation after resuscitation in adult severe TBI. Even when the criteria for adequate 












still experienced PbtO2 < 10 mmHg within the first hour after resuscitation. Episodes of low 
PbtO2 were associated with poorer outcome, suggesting that cerebral hypoxia concurrent 
with normal ICP and CPP is an important factor leading to secondary brain injury. Similar 
findings were demonstrated in a paediatric study conducted by Figaji et al 
41
 in which 
adherence to guideline treatment targets of ICP < 20 mmHg and CPP > 50  mmHg was 
associated with low PbtO2 (< 10mmHg) in approximately one third of patients. Of note, in a 
separate paediatric study the association between ICP and poor outcome was reduced when 
PbtO2 was included in multivariate analysis 
43
. 
Van den Brink et al 
138
 also found that PbtO2 was strongly associated with poor outcome, but 
PbtO2 values were not significantly associated with either high values of ICP of long 
duration (> 25 mmHg for ≥ 60 minutes) or low values of ICP. In a study using both SjvO2 
and PbtO2, Gopinath et al 
48
 found that elevated ICP was responsible for less than 50% of 
cerebral ischemic episodes.  
A number of these studies were limited by small sample sizes of less than 30 patients, but 
their results highlight important characteristics of low brain oxygenation and its relationship 
with ICP, suggesting that ICP seems to have a limited effect on PbtO2. While this may 
indeed reflect the general relationship for pooled data analysis between ICP and measures of 
brain oxygenation, it is important to note that ICP can have a very significant negative effect 
on PbtO2. This is clear, for example, in studies investigating the change in cerebral 
physiology subsequent to decompressive craniectomy (DC). 
Ho et al 
56
 conducted a study on 16 TBI patients who underwent DC for refractory 
intracranial hypertension. Their results indicated a significant decrease in ICP accompanied 
by a significant increase in PbtO2 post-DC. In paediatric TBI, Figaji et al 
40
 assessed the 
changes in ICP and PbtO2 following DC for elevated refractory ICP. When pre- and 
postoperative values for ICP and PbtO2 were compared, there was a significant decrease in 
ICP from 40 ±14.9 mmHg to 17 ±9.02 mmHg after surgery. This was accompanied by a 
significantly increase in PbtO2 from 18 ±12.8 mmHg to 43±15.4 mmHg, that was sustained 
after the operation. These findings suggest that ICP and PbtO2 may demonstrate a closer 
relationship in individual patients. 
Implications for treatment 
Current TBI treatment emphasises controlling ICP as one of the principle strategies for 
averting secondary ischemic injury after TBI, predominantly as a means of ensuring 
adequate CPP 
2, 18












indicates that ischemic damage may occur under circumstances of ‘normal’ CPP and ICP. 
This may be due to several factors, including inappropriately low CBF, vasospasm, increased 
barriers to oxygen diffusion, subclinical seizures, or metabolic derangement. It is equally 
possible that the currently used threshold for treating ICP, especially in children, is not 
optimal; therefore, what is considered normal ICP is not what should be optimally targeted.  
The relationship between ICP and brain oxygenation is poorly understood, but has important 
implications for treatment protocols, given that ICP has become a cornerstone of care, and 
that measures of brain oxygenation or perfusion are not commonly employed in the 
management of severe TBI. Treating at lower thresholds of ICP increases the risk of adverse 
effects associated with ICP-reducing therapies, and therefore over-treatment is not advisable. 
On the other hand, it is clear that ICP can have a marked effect on PbtO2 in some 
circumstances, which necessitates that significant elevations of ICP be treated. However, the 
level of ICP which would constitute a significant elevation is unclear, particularly in the 
paediatric context. Because there are dangers in both under-treating and over-treating ICP, 
and because the uncertainty of which ICP threshold to treat is greatest in children, a better 
















This study aimed to investigate the relationship between ICP and PbtO2 in depth for children 
with severe TBI. Consequently, analyses were conducted in a sequential manner, looking at 
the relationship first broadly, and then in increasingly defined and narrower analyses.  
1. To describe the profile of ICP and PbtO2 following TBI 
This analysis explored the profiles of ICP and PbtO2 following TBI by identifying the 
frequency of intracranial hypertension and low brain oxygenation as well as outlining their 
profile for the acute phase of monitoring post trauma. This described their trends in 
individual patients and across the cohort, and documented the time frames of highest ICP 
and lowest PbtO2. The purpose of this first analysis was to provide an overview of ICP and 
PbtO2 in this cohort of patients.  
2. To examine the time-linked relationship between ICP and PbtO2 
To investigate the direct relationship between ICP and PbtO2, analysis was conducted in a 
step wise fashion. The relationship was examined 1) using raw data of paired observations in 
pooled analysis, 2) controlling for variation between individuals, and 3) controlling for 
relevant systemic factors, namely MAP, CPP, PaO2, PCO2 and Hb. 
3. To explore critical thresholds for ICP and PbtO2 
This analysis aimed to examine key values of ICP in relationship to PbtO2 to explore 
whether critical ICP thresholds could be defined. Given the different thresholds of 
significance for PbtO2, these ICP values were examined against several thresholds of PbtO2 
from 20mmHg to 5mmHg. Receiver-operating characteristic curves (ROCs) were 
constructed for each of these thresholds. 
Since children may vary significantly from infancy to adolescence, age may potentially 
influence the point at which ICP negatively impacts on PbtO2. Therefore, age-related 
thresholds for ICP were investigated in 3 different age categories. 
Since TBI may exhibit substantial inter-individual heterogeneity in the ICP and PbtO2 












mask significant relationships seen in individual patients, additional ROCs for individual 
patients were constructed using hourly and electronic data.  
 
4. To illustrate relationships between ICP and PbtO2 in individual cases 
 
Values in PbtO2 and ICP may pass critical levels progressively and transiently; when 
averaged, these differences may be camouflaged 
37
. Therefore, it is possible that the 
relationship between ICP and PbtO2 values when averaged over a large cohort like in this 
study, or even over a long time period in a single patient, may appear weak. However, the 
association between ICP and PbtO2 may be very significant within an individual patient at 
particular time points.  Electronic data trends for individual patients were reviewed to find 
examples of the dynamic relationship between ICP and PbtO2. 
5. Data Capturing 
Data used for this analysis was predominantly extracted from hourly recordings taken during 
the monitored period in the ICU, and is the method by which data are commonly recorded 
and analysed in many studies However, large variation in physiological variables may occur 
in the space of one hour and may represent important physiological events. Continuously 
recorded data provides an uninterrupted complete account of physiological progress while 
hourly recordings provide a snapshot of the physiological state of the brain. Hourly data was 
therefore compared with high frequency collection of electronic data available (data points 
averaged over 10 second periods) to examine whether a substantial difference exists in the 



















Data collection for this project continued as part of an ongoing record of paediatric TBI data 
started in June 2006. Data were collected prospectively for paediatric patients admitted to 
Red Cross War Memorial Children’s Hospital who underwent ICP and PbtO2 monitoring for 
severe TBI (postresuscitation Glasgow Coma Score [GCS] of ≤ 8). All patients included 
were under the age of 15 years, in keeping with hospital policy. 
Indications for intracranial monitoring involved a postresuscitation GCS of ≤ 8 or 
deterioration to this level after admission. Monitoring was not considered for rapidly waking 
patients for whom early extubation was likely, if brain death was diagnosed, or the patient 
was considered to be unsalvageable on initial assessment (GCS 3/15, dark brain on 
admission head CT scan and fixed dilated pupils). Some patients were not monitored 
because PbtO2 catheters were not available or all the monitoring machines were in use. ICP 
and PbtO2 catheters were placed in an ipsilateral location in close proximity to each other. 
Informed consent was obtained from all parents before insertion of intracranial monitors. 
Resuscitation followed the Paediatric Advanced Trauma Life Support guidelines, patients 
underwent endotracheal intubation, had a CT head scan, and were mechanically ventilated in 
the paediatric intensive care unit (ICU). 
Data Collection 
Data was collected manually from patient clinical folders. With the recent addition of a 
computerised physiologic recording system, ICMPlus
®
 (University of Cambridge, U.K), 
electronic data for physiological variables of the last 16 patients were also recorded.  
Admission Clinical and Demographic Data 
General Data 
General demographic and clinical data collected on admission included: age of the patient, 
gender, weight and height, mechanism of injury, time of injury, other injuries sustained, 












Classification and Grading Systems 
The postresuscitation GCS score of each patient was recorded, and the motor component 
separately documented. The Paediatric Coma Scale was used for preverbal children 
122, 123
. 
Postresuscitation pupillary reactions were categorised as bilaterally reactive, unilaterally 
nonreactive, or bilaterally nonreactive. The influence of medications was excluded.  
Time sequence 
The following were also recorded: time of admission (after injury), time of monitor insertion 
(time from injury to monitor insertion), duration of monitoring, and length of stay in the 
ICU. 
Physiological Data 
Intracranial monitors were inserted as early as possible after admission to the ICU and 
monitoring continued until both ICP and PbtO2 were considered stable for > 48 hours, or 
until the patient died. Measures of ICP, CPP, PbtO2, core and brain temperature, saturation, 
as well as the ventilator inspired fraction of oxygen (FiO2) were recorded on an hourly basis 
as part of standard ICU procedure. Data were extracted from the ICU recording sheets for 
the time during which ICP and PbtO2 monitoring was in progress. With the addition of the 
ICMPlus
®
 software recording system, measures of ICP, PbtO2, MAP and brain temperature 
were also be captured in samples averaged every 10 seconds.  
Recordings of PaO2, PaCO2, haemoglobin (Hb) and saturation (SaO2) were obtained from 
arterial blood gas (ABG) samples taken routinely as per normal ICU protocols, and when 
clinically indicated. Serum sodium (Na) and Hb were documented from routine blood 
sample analysis. 
Patient Management 
Patient management was broadly based on current treatment guidelines for ICP and CPP in 
children 
2, 5
. In general this involved treating ICP that was ≥ 20mmHg, and PbtO2 that was < 
20mmHg. The cause of compromised PbtO2 was sought and treated when apparent; when 
this was not the case PbtO2 management followed an algorithmic approach. Further details 















All data were managed in Microsoft Excel. Data cleaning was conducted as follows: 
PbtO2 catheters were given a 2 hour settling period, and data during this time was excluded 
from analysis to avoid using potentially artefactual data from a stabilising catheter. Data 
from catheters that were incorrectly placed according to CT head scan (in grey matter rather 
than white matter) were not included, as was data from catheters placed in a pericontusional 
location. Where two catheters were inserted in the same patient, readings from the catheter 
located in normal-appearing ‘uninjured’ tissue were used, i.e. not in a pericontusional 
location. 
To avoid skewed data analysis, recordings from patients who were terminal on admission 
were excluded, as was terminal data beyond the first hour of PbtO2 = 0. Observations 
recorded during various dynamic tests, such as autoregulation or FiO2 tests, were also 
excluded. Physiological data were manually reviewed in a step-wise process identifying 
artefacts, clear outliers, transcription errors and missing data points. Data from ABGs were 
used in correlation analysis with PbtO2 and ICP observations recorded at the same time that 
the ABG was taken.  
 
Data Analysis 
1. Describing the profiles of ICP and PbtO2 following TBI 
Data used in this analysis included terminal data up to one hour of PbtO2 = 0 (single 
observation). Descriptive analysis on ICP and PbtO2 have been reported in terms of 
measures of central tendency; mean and median (where appropriate), and dispersion; range, 
inter-quartile range and standard deviation depending on the distribution of the observations. 
ICP and PbtO2 profiles were investigated as follows: 
PbtO2 
PbtO2 data for each patient were recorded as follows: lowest PbtO2 recorded during the 
monitoring period (PbtO2low), median PbtO2 in the first 24 hours of monitoring (mPbtO224) 
or part thereof, and the number of episodes of PbtO2 < 5, PbtO2 < 10 and PbtO2 < 20 
mmHg.  
The PbtO2 profile was then investigated according to the following categories: the average, 












patient data an overall PbtO2low and mPbtO224 were then calculated, as well as an average of 
the number of episodes of PbtO2 < 5, PbtO2 < 10 and PbtO2 < 20 mmHg. The temporal 
profile for each patient was investigated across the first seven days of monitoring post 
trauma, and the day of lowest PbtO2 was recorded. 
ICP 
ICP data for each patient was calculated as follows: the peak ICP recorded during the 
monitoring period (ICPpeak), median ICP in the first 24 hours of monitoring or part thereof 
(mICP24), and the number of episodes of ICP > 20 and ICP > 30 mmHg.  
The ICP profile was then examined in a similar manner to PbtO2: the average, standard 
deviation and range of ICP were calculated for the entire cohort. Using individual patient 
data an overall ICPpeak and mICP24 were then calculated, as well as an average of the 
number of episodes of ICP > 20 and ICP > 30 mmHg. The temporal profile for each patient 
was calculated across the first seven days of monitoring post trauma, and the day of highest 
ICP recorded. The number of patients being monitored for ICP and PbtO2 per day was also 
noted.  
Trends in other physiological variables were analysed, and a summary of these is included 
for the purpose of providing descriptive information about the patient sample. These 
included: descriptive data for CPP, PaO2 (kPa), PaCO2 (kPa), Hb (g/dl) and Na (mmol/L) 
calculated for the entire cohort. Since this study focuses specifically on ICP and PbtO2, no 
further investigation for these variables was conducted. 
2. Examining the time-linked relationship between ICP and PbtO2 
Step 2.1: Evaluating the general relationship 
Paired observations for ICP and PbtO2 were analysed with Spearman’s correlation. 
Thereafter, a general estimating equation (GEE) model was constructed to control for the 
inter-individual variation in ICP and PbtO2 when assessing the relationship between the 2 
variables. Additionally, simple logistic regression was performed to evaluate the relationship 
between ICP and PbtO2 dichotomised at 10 mmHg (PbtO2 < 10 mmHg and PbtO2 ≥10 
mmHg).  
Step 2.2: Controlling for potential confounding variables 
To examine whether controlling for other variables improved the observed relationship 












(dependent variable), and a GEE model controlling for MAP, PaO2, PCO2, CPP and Hb 
were conducted. Spearman’s correlation was also performed for PbtO2 and each of the 
controlled variables.  
This step analysed only ICP and PbtO2 data recorded in conjunction with ABG data, but was 
conducted using 2 data sets. The first set contained data for all variables mentioned above. 
The second set was a restricted version of the first, in which data was limited to reasonable 
values of PaO2 (< 50 kPa), PaCO2 (3-6 kPa) and Hb (> 7 g/dl). This was to further adjust for 
the effect of any extreme values in these parameters that could potentially bias the analysis 
results. 
3. Exploring critical threshold values of ICP and PbtO2 
To explore critical threshold values of ICP and PbtO2 the sensitivities and specificities of 
ICP values for PbtO2 values were investigated to examine the predictive value of ICP for 
PbtO2. The sensitivity of a specific ICP value (ICP=Y) can thus be interpreted as the 
proportion of cases of PbtO2 below the designated threshold (low PbtO2) it was able to 
detect for ICP ≥ Y (a positive test), and the specificity of an ICP value represents the 
proportion of cases of low PbtO2 when ICP ≥ Y.  
ICP and PbtO2 levels were investigated around critical values. PbtO2 (as the outcome 
variable) was dichotomised across three values: 1) PbtO2 < 5, and PbtO2 ≥ 5, 2) PbtO2 < 10, 
and PbtO2 ≥ 10, 3) PbtO2 < 20, and PbtO2 ≥ 20 mmHg. These categories were then each 
examined in relation to ICP collapsed into categories increasing in 5 mmHg increments. This 
allowed evaluation over narrow ‘bands’ of ICP: 1) ICP < 10, and ICP ≥ 10, 2) ICP < 15, and 
ICP ≥ 15, 3) ICP < 20, and ICP ≥ 20, 4) ICP < 25, and ICP ≥ 25, 5) ICP < 30, and ICP ≥ 30, 
6) ICP < 35, and ICP ≥ 35, 7) ICP < 40, and ICP ≥ 40 mmHg. Sensitivities and specificities 
for each of these bands of ICP values were calculated for each of the 3 levels of PbtO2 as 
outcome. The relative risk for each level of ICP for low PbtO2 was also calculated.  
Because there is a tradeoff between sensitivity and specificity for various threshold levels of 
ICP, to evaluate which threshold level would provide the best balance between sensitivity 
and specificity in detecting low brain oxygenation a receiver operating curve (ROC) was 
constructed. The ROC displays the efficacy of a range of tests (in this case ICP thresholds)  
by plotting sensitivity against 1-specificity with both axes ranging from 0 to 1.The diagonal 
of such a graph denotes that the test in question would accurately predict disease (in this case 
PbtO2 below the designated threshold) with no greater power than chance. The area under 












value than a random sample with a negative result, and equals 0.5 under the diagonal (null 
hypothesis). In the context of this study an area of 0.8 for example would mean that a 
randomly selected patient with low brain oxygenation would have an ICP value greater than 
that for a randomly selected patient with adequate brain oxygenation 80% of the time. The 
ideal ROC would lie against the y-axis and the top of the graph would then continue parallel 
to the x-axis at a particular value below which the test would be very specific, and above 
which it would be very sensitive. However, since it is unlikely to see an ideal graph in 
reality, the efficacy of a test in detecting disease would be found by examining how far the 
curve lies away from the diagonal in the direction of the y-axis and is indicated by the area 
under the curve, where the perfect curve would have an area of 1.0 
147
. In this way the ROC 
provides a graphic presentation of the entire spectrum of sensitivity and specificity pairs for 
varying ICP thresholds across a spectrum of possible threshold values; in so doing the ROC 
is a useful test to monitor how alterations in the decision level of ICP thresholds can affect 
its sensitivity and specificity 
26
. ROCs were constructed for ICP against PbtO2 < 5 mmHg, 
<10 mmHg, and < 20mmHg. 
4. Age-related thresholds 
To date little literature examining age-related ICP thresholds exists, and the most detailed 
categorization of age bands and ICP recommendations is provided by Chambers et al 
26
. 
Based on age-related BP thresholds as well as the age at which the biggest incremental 
change in BP occurs the authors suggested the following age bands and provide 
recommended ICP threshold values for each:  2-6 years (ICP < 6.4 mmHg), 7-10 years (ICP 
< 8.7 mmHg) and 11-15 years (ICP < 13 mmHg).  
Based on this work these age categories were adopted for this cohort for examination against 
PbtO2 to determine whether it improved the observed relationship between ICP and PbtO2: 
ICP threshold values were taken as 6 mmHg, 9 mmHg and 13 mmHg for each of the age 
groups respectively (rounded to the nearest whole number). Threshold values for each group 
were then designated the symbol ‘X’ (therefore X= 6, 9, 13 mmHg depending on the age 
category). PbtO2 was dichotomized for PbtO2 < 10 mmHg and PbtO2 ≥10 mmHg. This 
dichotomized data for each patient were then sorted for 1) ICP < X, and ICP ≥ X, 2) ICP 
<(X+5) and ICP ≥ (X+5), and 3) ICP < (X+10) and ICP ≥ (X+10) to examine the thresholds 
for ICP with age taken into account. Therefore, data was essentially interrogated in terms of 
3 ICP levels: threshold, threshold + 5 mmHg and threshold + 10 mmHg. The sensitivities 
and specificities of these values of ICP were then investigated in the same manner as 












5. Evaluating the relationship between ICP and PbtO2 in individual patients 
Using hourly and electronic data (where available) ROCs for individual patients were 
constructed. Where electronic data was used, median ICP and median PbtO2 were calculated 
over 1 hour periods for the duration of monitoring in each patient. Artefacts were identified 
and excluded. Median ICP was plotted against median PbtO2 in ROCs for PbtO2 < 10 and  
<20 mmHg and the diagnostic accuracy of ICP was indicated by the area under each curve.  
6. Case Illustrations 
Electronically recorded continuous data were interrogated to search for demonstrations of the 
dynamic relationship between ICP and PbtO2.  
For examination of trends reflecting the relationship between ICP and PbtO2 exclusively, 
data points relating to external manipulation, such as suctioning, patient handling, increasing 
the FiO2, augmenting BP, autoregulation testing, as well as any clearly artefactual data 
points were excluded. Using the ICMPlus program a moving correlation coefficient between 
the means of ICP and PbtO2 was calculated over 2 minute intervals and plotted as a 
continuous trend. The means for ICP, PbtO2 and the correlation coefficient were calculated 
for the duration of the identified event. 
When examining the role of pressure autoregulation MAP trends were also considered. 
7. Data Capturing 
To examine the relationship between manual and electronic recording of physiological data, 
the following was calculated: 1) hourly data were compared with electronic data averaged 
over the half hour preceding and following the corresponding hour (mean-hour), 2) the 
number of episodes of ICP > 20 mmHg and PbtO2 < 20 mmHg lasting 5 minutes or longer 
were compared with the number of episodes recorded across hourly data.  Analysis was 
conducted with the first 24 hours of complete data available.  
In keeping with the recommendations of Bland and Altman 
12
 the degree of agreement 
between electronic and hourly recorded data for mean-hour was calculated as outlined: Mean 
ICP and mean PbtO2 were calculated using electronic and hourly ICP and PbtO2 readings. 
The mean difference between electronic and hourly ICP data was then calculated and plotted 
against mean ICP, and the mean difference between electronic and hourly PbtO2 data was 
calculated and plotted against mean PbtO2.  In order to summarise the degree of agreement 
between these two measurement techniques, for each of the graphs two lines of agreement 












These lines indicate the extent to which values vary about the mean difference and therefore 
the extent to which electronic and hourly data differ from each other. Variation within two 
standard deviations suggests adequate agreement between the two recording measures. 
Provided that differences within two standard deviations would not be of clinical importance 
these techniques could then be used interchangeably. The number of episodes of high ICP or 















Data for 81 patients who underwent ICP and PbtO2 monitoring for severe TBI from June 
2006 to June 2009 were collected. Data from 5 patients were excluded due to incorrect or 
penumbral placement of the catheter (n=3) or because the patient was terminal on admission 
(n=2). Terminal data excluded from the 75 remaining patients accounted for 7% of the total 
number of observations, dynamic tests such as autoregulation and FiO2 tests accounted for 
0.3% and missing data points accounted for 8.7%. Exclusion of data was distributed across 
the cohort. 
 
Admission Clinical and Demographic Data 
Demographic and admission clinical data are summarised in Table 1. The age distribution of 
this cohort was as follows: < 2 years (n=11, 14.7%), 2-6 years (n=32, 42.7%), 7-10 years 
(n=20, 26.7%), and 11-15 years (n=12, 16%). 
Time sequence 
The median number of hours to monitoring post injury was 7 (IQR 7-17 hours). Monitoring 
was started ≤ 12 hours after injury in 44 patients (66.7 %), between 13 and 24 hours in 16 
patients (24.2%) and > 24 hours in 6 patients (9%). The average duration of monitoring was 
5.8 ± 3.2 days (range 1-15 days), and on average patients stayed in ICU for 7.9 ± 4.2 days 
(range 1-21 days). 
Physiological Data 
Physiological data for the patient cohort are summarised in Table 2. Technical problems 
were encountered with 2 ICP catheters which required replacement. No technical problems 
arose with PbtO2 catheters, although both PbtO2 and ICP catheters had to be replaced in one 
patient in whom they were inadvertently pulled out. CT scans were checked to ensure that 
catheter placement was correct in all patients. Data were excluded from analysis from 
patients where the catheter had been misplaced in grey matter on follow-up head CT scans 














Admission clinical and demographic characteristics (N= 75) 
Characteristic Value 
Age 6.4 ± 3.5 years (4 months – 14 years) 
Gender Male 49 
 Female 26 
Post resuscitation GCS 3 
 GCS 3 3 
 GCS 4 12 
 GCS 5 14 
 GCS 6 18 
 GCS 7 14 
 GCS 8 11 
Motor component of GCS (median, range) 4 (1- 5) 
Pupil reaction on admission  
 Bilaterally reactive 57 (76%) 
 Unilaterally nonreactive 4 (5.3%) 
 Bilaterally nonreactive 10 (13.3%) 
Initial Hb 9.9 ± 1.7 
Mechanism of Injury  
 MVA passenger 17 (22.6 %) 
 MVA pedestrian 43 (57.3 %) 
 Crush injury 3 (4 %) 
 Gunshot to head 4 (5.3 %) 
 Fall from height 1 (1.3 %) 
 Stab to head 2 (2.6 %) 
 NAI 2 (2.6 %) 
 Blunt head injury/assault 2 (2.6 %) 
 Other 1 (1.3 %) 
Polytrauma 46 (61.3 %) 
Note: Values are expressed as mean ± SD (or median and range were specified) or as numbers and proportions. 
Patients who did not have a postresuscitation GCS ≤ 8 deteriorated to this level after admission.  Polytrauma was 
defined as all injuries to organ systems other than the head, excluding superficial wounds. MVA: Motor vehicle 













Summary of physiologic monitored variables for total monitored time  
Variable Value 
PbtO2 (mmHg) 32.6 ± 12.7 Range (0-98.9) 
MAP (mmHg) 81.8 ± 13.1 
ICP (mmHg) 14.5 ±7.7 Range (0-100) 
CPP (mmHg) 67.16 ± 15.09 
PaO2 (kPa) 17 (12.2-25) Range (4.2-78.1) 
PaCO2 (kPa) 4.6 ± 1.1 
SaO2 (%) 99 (98-100) Range (30-100) 
FiO2 (%) 40 (40-60) Range (10-100) 
Haemoglobin (g/dl) 10.8 ± 1.8 
Serum sodium (mmol/L) 143 ± 4.0 
Note: Values reported as mean ± SD, or median, IQR and range depending on distribution characteristics of 




1. Describing the profiles of ICP and PbtO2 following TBI 
Data used to examine the profiles of ICP and PbtO2 totalled 9452 hourly observations. 
Profiles for ICP and PbtO2 are summarised in Table 3. 
Values for mPbtO2, mPbtO224 and median PbtO2low were 32.6 mmHg, 29.7 mmHg and 
12.1 mmHg respectively. Despite treatment aimed at maintaining PbtO2 > 20 mmHg, 66 
patients experienced episodes of PbtO2 < 20 mmHg (88%), 35 patients experienced PbtO2  
<10 mmHg (46.7%), and 14 had episodes of PbtO2 < 5 mmHg (18.7%). The mICP for the 
monitoring period was 14.5 mmHg and the median for the first 24 hours of monitoring was 
13.76 mmHg. ICP peaked at an average of 33.6 mmHg; 63 (84%) patients experienced 















PbtO2 and ICP Profiles 
PbtO2   (mmHg)  
 PbtO2 low Mdn 12.1 (7.3-16.8) Range (0.5-29.1) 
 PbtO2 24 Mdn 29.71 (23.7-34.98) Range (2.1-56) 
 PbtO2 < 5 (no. of episodes) Ave 4.92  Range  (1-16) 
  Number of patients 14 (18.7%) 
 PbtO2 <10 (no. of episodes) Ave 4.74  Range (1 -22) 
  Number of patients 35 (46.7%) 
 PbtO2 < 20 (no. of episodes) Ave 17.3 Range (1-122) 
  Number of patients 66 (88%) 
ICP    (mmHg)  
 ICP peak Mdn 30 (22-41) Range (9-99) 
 ICP24 Mdn 13.76 (10.83-18.17) Range (2.6-60.7) 
 ICP > 20 (no. of episodes) Ave 27.2 Range (1-142) 
  Number of patients 63 (84%) 
 ICP > 30 (no. of episodes) Ave 7.4 Range (1-48) 
  Number of patients 40 (53.3%) 
Note: Calculated from individual patient values. Values reported as median, IQR and  range, or average and  
range where specified. 
The temporal outline of ICP and PbtO2 trends for the first week of monitoring are 
graphically displayed in Figures 1 and 2. Mean PbtO2 over the first week was 32.4 ± 3.8 
mmHg. The mPbtO2 increased from day 1 to day 6, after which it began to decrease. The 
difference between days was most marked between days 1 and 2 which exhibited a 5.7 
mmHg increase on average. The day of lowest mPbtO2 was day 1 (24.5 mmHg) and the day 
of highest mPbtO2 was day 6 (34.9 mmHg). 
Mean ICP during the first week of recording was 14.2 ± 2.18 mmHg. There was little change 
in mean values for ICP over the whole of the first week. Mean ICP declined slightly from 
day 1 to day 5, after which it rose again slightly over days 6 and 7. The greatest change in 
ICP occurred between days 1 and 2 in which time ICP decreased by 1.2 mmHg. The day of 






























The number of patients who had monitored data increased from day 1 to day 2 post-injury 
(Table 4), largely due to the later insertion of catheters in many patients. Fewer patients were 
monitored as the week progressed, reflecting patient recovery and discontinuation of 
monitoring. By the third day 60% of patients had experienced their highest ICP value, but 
ICP continued to peak in some patients until after day 7. Lowest PbtO2 values were recorded 
in more than 70% of patients by day 3, but low values continued to occur beyond day 7. 
Table 4 
ICP and PbtO2 during the first week of monitoring 












1 56 14 18.67 25 33.33 
2 69 15 38.67 19 58.67 
3 69 17 61.33 11 73.33 
4 61 8 72 4 78.67 
5 53 6 80 3 82.67 
6 43 6 88 7 92 
7 34 6 96 2 94.67 
 
Note: Column 3 and 5 reflect the number of patients who experienced their highest ICP or lowest PbtO2 on that 
respective day. These are expressed as percentages of the cohort of 75 patients in the 4th and 6th column. 
 
2. Examining the time-linked relationship between ICP and PbtO2 
Step 2.1: Evaluating the relationship in general 
Analyses for paired ICP and PbtO2 observations were performed on data which excluded all 
terminal and missing data points. Spearman’s correlation using 8389 observations revealed a 
positive weak correlation between ICP and PbtO2 (r = 0.05, p < 0.01). The scatter plot is 
provided in Figure 3. The GEE model indicated that controlling for inter-individual variation 
also did not reveal a significant relationship between ICP and PbtO2 (p =0.86), but that 
intra-individual PbtO2 values were influenced by individual characteristics (intraclass 
coefficient = 0.33, p < 0.01). Logistic regression showed that higher values of ICP were 












again weak (estimate = -0.075, p < 0.01). The odds ratio was 0.93, with a confidence 
interval of 0.92 – 0.94. 
 
Figure 3 
Scatter plot: Correlation between ICP and PbtO2 
 
 
Step 2.2: Controlling for potential confounding variables 
Linear regression analysis for ICP and PbtO2 controlling for MAP, CPP, PaO2, PaCO2 and 
Hb was performed. Results from neither the unrestricted (400 observations) nor the restricted 
data set (334 observations) revealed a significant relationship between PbtO2 and ICP         
(r = -0.107, p =0.27) and (r= -0.104, p =0.32). Therefore, controlling for these additional 
variables did not improve the observed relationship between ICP and PbtO2; however, much 
fewer data points were used than in the pooled analysis of all observations for ICP and 
PbtO2. Only MAP, CPP and PaO2 showed a significant although weak positive relationship 
with PbtO2. Results from the GEE models differed across the 2 data sets in terms of PaCO2; 
the unrestricted data set indicated that PaCO2 had a significant positive relationship with 












whereas the restricted data set did not exhibit this relationship. Correlations between PbtO2 
and ICP, MAP, CPP, PaO2, PaCO2 and Hb are shown in Table 5. 
 
Table 5 
Table of Correlations with PbtO2: Linear Regression 
Variable 
Correlation Value (r) 
Unrestricted Data Restricted Data 
ICP -0.07 -.05 
MAP 0.22* 0.18* 
CPP 0.22* 0.19* 
PaO2 0.18* 0.14* 
PaCO2 -0.1 -0.15 
Hb -0.07 -0.04 
Note: * Denotes significant correlations (p < 0.01). 
 
3. Exploring critical threshold values of ICP and PbtO2 
A total of 8389 data points for ICP and PbtO2 less terminal data were used for this analysis. 
Frequencies for data dichotomized for PbtO2 of 5, 10 and 20 mmHg and for ICP 
dichotomized across 5, 10, 15, 20, 25, 30, 35, and 40 mmHg are summarised in Table 6. The 
sensitivities and specificities for each of these data sets are shown in Table 7. 
3.1 Sensitivity and specificity 
An ICP threshold of 20 mmHg (ICP ≥ 20) detected 64% of episodes of PbtO2 < 5 mmHg 
(i.e. 64% of the total number of these episodes occurred when ICP was ≥ 20), 42% of PbtO2 
< 10 mmHg, and 29% of PbtO2 < 20 mmHg. The specificity for ICP of 20 mmHg was 
approximately 81% for all categories of PbtO2 thresholds. An ICP of 15 mmHg detected 
79% of PbtO2 < 5 mmHg, 61% of PbtO2 < 10 mmHg, and 51% of PbtO2 < 20. This level of 
ICP demonstrated a specificity of approximately 55% in all cases of PbtO2. These results 
indicate that an ICP threshold of 15 mmHg detects more cases of lower brain oxygenation 
than a threshold of 20 mmHg for the same threshold values of PbtO2, but that only about 
half of the cases detected do in fact have low brain oxygenation. ICP thresholds of 20, 15 












threshold value of PbtO2 increased. As PbtO2 decreased, higher ICP values picked up 
proportionally more numbers of low PbtO2, suggesting that the lower the PbtO2, the more 
likely it is associated with high ICP. As ICP thresholds increased sensitivity for low brain 
oxygenation decreased (more episodes of low PbtO2 were detected at lower ICP thresholds), 
but specificity increased. The fact that all ICP thresholds exhibited similar specificity levels 
for each category of PbtO2 may be explained by the fact that the overwhelming number of 
observations always fell into the disease negative (PbtO2 greater than threshold) and test 
negative (ICP lower than threshold) categories, with which specificity is calculated. 
Therefore the proportions between disease negative and test negative frequencies were 
relatively similar for all ICP thresholds and all PbtO2 categories. 
 
Table 6 












 PbtO2 < 5 PbtO2≥ 5 PbtO2< 10 PbtO2≥ 10 PbtO2 <20 PbtO2≥ 20 
Total 56 8333 154 8235 1113 7276 
ICP < 10 4 1990 27 1966 240 1753 
ICP ≥ 10 52 6343 127 6269 873 5523 
ICP < 15 12 4627 60 4579 544 4095 
ICP ≥ 15 44 3706 94 3656 569 3181 
ICP < 20 20 6765 89 6696 786 5999 
ICP ≥ 20 36 1568 65 1539 327 1277 
ICP < 25 29 608 116 7638 956 6798 
ICP ≥ 25 27 7725 38 597 157 478 
ICP < 30   120 8003 1044 7079 
ICP ≥ 30   34 232 69 197 
ICP < 35     1070 7189 
ICP ≥ 35     43 87 
ICP < 40   124 8180 1076 7228 
ICP ≥ 40   30 55 37 48 
Note: The number of ICP levels calculated for each value of PbtO2 was dependent on the availability of sufficient 




















 PbtO2 = 5 
 
Sensitivity Specificity 
ICP = 10 92.85 (82-98) 23.88 (22-24) 
ICP = 15 78.57 (65-88) 55.52 (54-56) 
ICP = 20 64.28 (50-76) 81.18 (80-82) 







PbtO2 = 10 
 Sensitivity Specificity 
ICP = 10 82.46 (75-88) 23.87 (22-24) 
ICP = 15 61.03 (52-68) 55.6 (54-56) 
ICP = 20 42.2 (34-50) 81.31 (80-82) 
ICP = 25 24.67 (18-32) 92.75 (92-93) 
ICP = 30 22.07 (15-29) 97.18 (96-97) 








PbtO2 = 20 
 Sensitivity Specificity 
ICP = 10 78.43 (75-80) 24.09 (23-25) 
ICP = 15 51.12 (48-54) 56.28 (55-57) 
ICP = 20 29.38 (26-32) 82.44 (81-83) 
ICP = 25 14.1 (12-16) 93.43 (92-93) 
ICP = 30 6.19 (4-7) 97.29 (96-97) 
ICP = 35 3.86 (2-5) 98.8 (98-99) 
ICP = 40 3.32 (2-4) 99.34 (99-99) 















3.2 Relative risk 
The relative risk for each level of ICP per category of PbtO2 is presented in Table 8 and the 
change per ICP threshold is plotted in Figures 4-6. The likelihood of PbtO2 < 5, 10 and 20 
mmHg occurring increased as the value of ICP increased. The largest increase in relative risk 
per threshold value of ICP was seen for PbtO2 = 5 mmHg, for which the median change was 
3.08 % (0.48 – 3.75 %). However, the most marked increase in relative risk was between 
ICP = 30 mmHg and ICP = 40 mmHg for PbtO2 < 10 mmHg (14.98%). The likelihood of 
PbtO2 < 10 was 1.15% greater for an ICP threshold of 20 mmHg than for ICP of 15 mmHg, 
and the likelihood of PbtO2 < 20 was only 0.46 % greater for ICP of 20 mmHg in 
comparison to ICP of 15 mmHg.  
Table 8 
Relative Risk: PbtO2 = 5  
ICP Relative Risk 
ICP = 10 4.05 (1.41-13.16) 
ICP = 15 4.53 (2.32-9.05) 
ICP = 20 7.61 (4.29-13.6) 
ICP = 25 11.37 (6.57-19.66) 
Relative Risk: PbtO2 = 10  
ICP Relative Risk 
ICP = 10 1.46 (0.96-2.27) 
ICP = 15 1.94 (1.39-2.7) 
ICP = 20 3.09 (2.25-4.28) 
ICP = 25 4.0 (2.75-5.8) 
ICP = 30 8.65 (5.9-12.53) 
ICP = 40 23.64 (16.31-32.86) 
Relative Risk: PbtO2 = 20  
ICP Relative Risk 
ICP = 10 1.13 (0.99-1.3) 
ICP = 15 1.29 (1.16-1.45) 
ICP = 20 1.76 (1.56-1.98) 
ICP = 25 2.0 (1.72-2.33) 
ICP = 30 2.02 (1.61-2.49) 
ICP =35 2.55 (1.94-3.26) 
ICP = 40 3.36 (2.53-4.25) 












Charts of Changes in Relative Risk for ICP 
Figure 4: PbtO2 = 5 mmHg 
 
Figure 5: PbtO2 = 10 mmHg 
 














The ROCs for ICP in general were poor, and the curves mostly lay close to the diagonal line. 
The area under the curve was 0.778 for PbtO2 < 5 mmHg, 0.631 for PbtO2 < 10 mmHg, and 
0.559 for PbtO2 < 20 mmHg. The ICP threshold value with the best combination of 
sensitivity and specificity was approximately 15.5 mmHg for PbtO2 < 5 and < 10 mmHg, 
and 19.5 mmHg for PbtO2 < 20 mmHg. The three ROCs are depicted in Figures 7-9. 















4. Age-related thresholds 
Frequencies for data dichotomized for PbtO2 = 10 mmHg and for ICP of X, (X+5) and 
(X+10) are outlined in Table 10. ICP = X [6, 9, 13 mmHg] detected just over 90% of cases 
of PbtO2 < 10 mmHg but only had a specificity of about 19%. ICP = (X+5) [11, 14, 18 
mmHg] had a sensitivity of 63.3 % for PbtO2 < 10 mmHg and a specificity of 46.3%. 




Frequency table for age-related ICP thresholds 
 PbtO2 < 10 PbtO2 ≥ 10 
Total 147 6648 
ICP < X 14 1246 
ICP ≥ X 133 5402 
ICP < (X+5) 54 3076 
ICP ≥ (X+5) 93 3572 
ICP < (X+10) 86 4978 
ICP ≥ (X+10) 67 1670 
 
 
The age-related ROCs (Figures 10-12) were no stronger than those plotted for the entire 
sample and the curve for age group 7-10 years even fell below the diagonal. The area under 
the curve was 0.733 for 2-6 years, 0.438 for 7-10 years, and 0.785 for 11-15 years. The fact 
that the 7-10 year ROC fell below the diagonal may be explained firstly by the weak 
relationship between ICP and PbtO2 in general, and secondly, by the fact that low values of 
PbtO2 in 2 of the patients in this age group were attributed to other causes; one patient had 
probable fat embolism syndrome, and the second patient suffered from multiple organ 
dysfunction syndrome (MODS).  However, although the area under the ROC improved 
somewhat after these 2 patients were excluded, the curve still remained below the diagonal. 
It is also possible that the thresholds selected for the age groups, or even the range of ages 
selected for these groups, are not optimal. However, there is no better data for age-related 


























5. Evaluating the relationship between ICP and PbtO2 in individual patients 
ROCs for individual patients showed significant variation but in general were not better than 
ROCs for pooled data. ROCs for 3 patients are selected here (Figure 13-15) to illustrate the 
differences in curves obtained; one patient had an ROC which lay above the diagonal (area = 
0.64), another had an ROC which fell below the diagonal (area = 0.28), and the third 
patient’s ROC crossed the diagonal (area = 0.58). These findings suggest that the 
relationship between ICP and PbtO2 demonstrates heterogeneity among individual patients, 
and that the association between ICP and compromised PbtO2 may vary between 
individuals, which influences the general relationship observed in ROCs for pooled data. 
Figures 13 – 15 















6. Case Illustrations 
Interrogation of electronic data revealed a number of different patterns between ICP and 
PbtO2.  
Linear negative relationship: Figure 16 and 17 depict a linear negative relationship between 
ICP and PbtO2 in the context of stable MAP and systemic oxygenation. The mean 
correlation coefficients between ICP and PbtO2 for the spike in Figures 16 and 17 were        
-0.72 and -0.55 respectively, suggesting that ICP had a strong negative influence on PbtO2. 
The lower coefficient for Figure 17 may be explained by the fact that there is a slight delay 
in the drop in PbtO2 following the ICP rise, and also by the fact that ICP spikes initially 
precipitously and then drops to a slightly lower level; this event could result in a transient 
positive correlation which would lessen the average correlation coefficient. Figure 18 depicts 
a 5-hour period in which several examples of the negative linear change in ICP and PbtO2 















Figure 16  
Illustrations of the negative linear relationship between ICP and PbtO2 





















Linear positive relationship: Figure 19 highlights a period of approximately 4.5 hours across 
which a number of examples of a positive relationship between ICP and PbtO2 are observed 
(not related to external handling). The correlation coefficients for the ICP spikes are low, 
with the highest coefficient being 0.22 for the ICP spike occurring at 10:30. Reasons for this 
may be once again the delay in the take-off in PbtO2, and also the fluctuating nature of the 
ICP peak, but the temporal relationship between the 2 variables is clear. MAP throughout 
this period was stable. 













Changes in ICP and PbtO2 as a function of pressure autoregulation: Figure 20 illustrates 
how impaired pressure autoregulation (confirmed with transcranial Doppler) can result in a 
simultaneous increase in ICP and PbtO2 during an increase of MAP. The increase in MAP is 
accompanied by an instantaneous rise in ICP and a slightly delayed increase in PbtO2. These 









The complex interplay between ICP and PbtO2: Figure 21 represents a summary of the 
possible ways in which ICP, PbtO2 and MAP may interact in a single patient over a 
restricted period of time; A denotes an impaired autoregulatory response, B demonstrates a 
positive relationship between ICP and PbtO2 which changes its course at C where ICP seems 
to have passed a critical point at which PbtO2 begins to decline. D indicates a negative 














Complex relationship between ICP, PbtO2 and MAP 
     A        B         C           D 
 
 
7. Data Capturing 
A total of 216 hours (selected from a 24 hour period) were used for the ICP and PbtO2 
analysis of manual versus electronic data collection methods. 
Mean hour 
Bland Altman graphs for mean-hour ICP and PbtO2 electronic and hourly data are shown in 
Figures 22 and 23. Approximately 95% of all values for ICP and PbtO2 fell within the limits 
of agreement. The mean difference for ICP was -0.62 ±2.3 mmHg and -0.11 ±5.34 mmHg 
for PbtO2 (calculated as hourly – electronic). This suggests that approximately 95% of 
electronic and hourly data do not differ by more than 4.51 mmHg for ICP and 10.47 mmHg 
for PbtO2.  
Distribution for mean-hour data was random about the mean, and did not present any trends 
which might suggest that values in the two techniques may differ in terms of level, with one 
consistently reporting higher or lower values than the other. There was also no indication 
that the difference between readings of these two techniques demonstrated different patterns 












Figures 22 and 23 















Number of episodes of high ICP and low PbtO2 
Of a total recording time of 1364 hours for 9 patients, 452 episodes of ICP > 20 mmHg for 
≥5 minutes were recorded digitally (33%), and 253 episodes hourly (18.5%). The difference 
in these proportions was significant (z=8.91) suggesting that high frequency recording 
captured a more detailed account of the profile of ICP. The number of episodes of PbtO2 
<20 mmHg recorded electronically was 224 (16.4%), and 219 hourly (16%). There was no 
significant difference between these proportions suggesting that hourly and high frequency 
















This study examined time-linked ICP and PbtO2 observations in a cohort of 75 children with 
severe TBI (mean age 6.4 years, median GCS 6). This is an important topic considering that 
ICP treatment is the cornerstone of care for severe TBI in most centres. The purpose of 
treating ICP is to preserve brain oxygenation or perfusion and to avoid herniation, but 
evidence suggests that cerebral ischemia may occur despite ICP control and stable 
cardiorespiratory physiology. Different methods of brain oxygenation monitoring exist, and 
although measures of compromised brain oxygenation, like low PbtO2, appear to be strongly 
associated with poor outcome, often none of these monitors are used.  Therefore, a better 
understanding of the relationship between ICP and PbtO2 would appear to be of relevance, 
particularly for children, in whom much less in known about both ICP and PbtO2.  
The main findings of this study were that the relationship between ICP and PbtO2 is poor, 
and is variable between different patients and at different times. Several methods of 
analysing the data were employed, including correlation of all pooled data, controlling for 
inter-individual differences, controlling for other influencing variables, calculation of 
sensitivity and specificity of critical thresholds for ICP with  PbtO2 as the outcome variable, 
construction of ROCs for ICP and PbtO2 (while taking 3 age bands into account), 
construction of ROCs for individual patients, and exploration of electronic data for case 
illustrations of the continuous relationships between ICP and PbtO2. The pattern of the 
relationship between ICP and PbtO2 is consistent across all of these analyses. This is likely 
because 1) there are several other variables that influence PbtO2, and 2) although high ICP 
has a negative influence on PbtO2, other factors (e.g. hyperaemia) may cause changes in ICP 
and PbtO2 that occur in parallel. Further confounding this relationship may be the inclusion 
of several age ranges in which the physiological norms are rapidly changing and for which 
we do not have clarity for optimal specific ICP and CPP thresholds for management.   
 
 ICP and PbtO2 profiles following pTBI 
Despite attempts to adhere to treatment thresholds for ICP and PbtO2, perturbations in these 
variables were frequent in this patient group. Episodes of PbtO2 < 20 mmHg were seen in 












< 5 mmHg. ICP > 20 mmHg occurred in 84% of the children, and over half had episodes of 
ICP > 30mmHg. These data confirm the high prevalence of secondary intracranial 
hypertension and cerebral hypoxia/ischemia following paediatric severe TBI. 
The time-course for ICP and PbtO2 in this study resembles that of other studies, with 
elevated ICP and reduced PbtO2 occurring most commonly early after injury, but with some 
delayed intracranial hypertension and cerebral hypoxia also present. Temporal patterns of 
PbtO2 and ICP derangements were similar but their values opposite, as expected. The 
progressive decrease in ICP over the first 5 days was accompanied by a progressive increase 
in PbtO2 over that time. The largest decrease in ICP and largest increase in PbtO2 both 
occurred between days 1 and 2. The highest mICP and lowest mPbtO2 were recorded on day 
1, the lowest mICP and highest mPbtO2 were seen on days 5 and 6, and by day 3 over 60% 
of patients had experienced their peak ICP and lowest PbtO2. However, for individual 
patients ICPpeak and PbtO2low were not necessarily related. The average difference in the 
days between ICPpeak and PbtO2low was 2 days, range (0-13 days). Even when the largest 
differences of 9 and 13 days were excluded, the mean difference was still 1.74 days.  
The decrease in ICP and increase in PbtO2 over time after the injury probably reflect the 
normal course of patient recovery. The median time for monitoring was 5 days, by which 
time most patients had experienced their highest ICP and lowest PbtO2 values and were 
becoming more stable. Delayed intracranial hypertension may be due to events such as 
delayed cerebral oedema. While this is a potential cause of delayed cerebral hypoxia, 
additional factors like polytrauma may also be a source of late desaturation, as in the case of 
progressively deteriorating respiratory injury. Injury severity is also an important factor that 
can significantly affect the time course of all cerebral variables independently of each other, 
where prolonged perturbations in ICP and PbtO2 are functions of the extent of the primary 
injury and its immediate aftermath rather than being directly linked to each other. 
It must also be considered that these profiles have been derived from hourly values. A more 
accurate manner of assessing the time course of ICP and PbtO2 may be in the investigation 
of electronic high frequency data which provides a complete picture of their tends across 
time. However, hourly recordings appear to approximate averages for observations within 
the hour (see below). 
It is possible that a phase difference may occur in the time course of changes for ICP and 
PbtO2, however attempting to conduct the analysis in consideration of this would be beyond 












The time-linked relationship between ICP and PbtO2 
Based on the rationale of improving brain oxygenation by ICP monitoring and control, it 
would be reasonable to anticipate that ICP has a significant negative linear relationship with 
PbtO2. Analyses using a very large number of observations, adopting several statistical 
methods and controlling for several potentially confounding variables did not demonstrate 
this, but revealed only a very weak relationship between ICP and PbtO2. This even had a 
positive slope in the initial part of the scatter plot, only becoming negative at higher values 
of ICP. While this was a statistically significant result, this may be due to the very large 
number of data observations. Moreover, it is essentially the r-value which is clinically 
important as it indicates the strength of association between ICP and PbtO2, which was in 
this case weak (r = 0.05).  Although this would seem to suggest that ICP has little overall 
negative impact on brain oxygenation, especially below thresholds or with mild to moderate 
intracranial hypertension, these results should be interpreted with caution and it should not 
be assumed that the relationship between ICP and PbtO2 is straightforward. Similar to the 
studies of ICP-directed treatment versus CPP-directed treatment 
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 it may be worth 
examining ICP and PbtO2-directed treatment. Presently, a phase II trial of PbtO2-directed 
treatment is planned in adults, but nothing is planned in the paediatric population to our 
knowledge. 
 
Exploring critical threshold values of ICP and PbtO2 
ROCs did not show high diagnostic accuracy for any of the levels of ICP in detecting low 
brain oxygenation (tested at various thresholds of low PbtO2) and were poorest for PbtO2 = 
20 mmHg. Taking age bands into consideration did not improve the demonstration of a 
relationship between high ICP and low PbtO2. All the ROCs constructed for pooled data 
were generally poor; not an unexpected finding given the poor correlation observed between 
ICP and PbtO2. ROCs for individual patients confirmed that the relationship between ICP 
and PbtO2 is complex, and that it is probably influenced by several factors of physiology and 
pathology that differ between individuals.  
The sensitivities and specificities of differing levels of ICP for varying levels of PbtO2 were 
investigated in order to evaluate whether they would resemble or support ICP treatment at 
the currently recommended threshold. In general, as the ICP threshold increased, sensitivity 
decreased (accounted for by the decreasing proportion of total hypoxic episodes for 












hypoxic episodes accounted for a larger proportion of all the PbtO2 observations as ICP 
increased). These sensitivities and specificities indicate that the recommended ICP threshold 
of 20 mmHg detected 42% of episodes of PbtO2 < 10 mmHg and 29% of PbtO2 < 20 
mmHg. As may be expected, a lower threshold of ICP captured more episodes of low PbtO2, 
with ICP of 15 mmHg detecting 61% of PbtO2 < 10 and 51% of PbtO2 < 20 mmHg. This 
does not suggest that treating ICP at 15 mmHg would avoid these additional episodes of low 
PbtO2, since they may merely reflect brain hypoxic/ischemic episodes unrelated to ICP, or 
the fact that a greater number of observations fell into lower ICP threshold categories (i.e. 
there were more observations for ICP>15 than for ICP>20). These sensitivities indicate that 
ICP thresholds of 20 mmHg and 15 mmHg essentially miss between 40% and 70% of all 
cases of low PbtO2 (PbtO2 < 10 and < 20 mmHg). This reiterates the important point that 
other factors are responsible for compromised brain oxygenation in as much as 60% of cases 
of cerebral hypoxia.  
Although a larger proportion of PbtO2 values were low as ICP increased, even when ICP 
was substantially increased, PbtO2 was not necessarily decreased in all patients. For 
example, when ICP was greater than 40 mmHg (n=85, Table 6), over half of the PbtO2 
observations were still greater than 20mmHg. However, it is important to note that this may 
reflect the effectiveness of PbtO2 intervention. Age-related thresholds detected 90% of cases 
of low PbtO2, which may merely reflect that these thresholds for ICP are relatively low. The 
specificity was less than 20%. 
From these analyses no single critical threshold of ICP demonstrated a marked effect on 
sensitivities and specificities for low PbtO2, but the relative risks for low PbtO2 increased 
progressively as the ICP threshold increased, mainly for PbtO2 < 10 and PbtO2 < 5 mmHg . 
Therefore, while it is clear that high ICP does pose a risk for lower PbtO2, there is 
substantial variability about this relationship, and no particular threshold indicated by these 
results. These are important findings, especially for children in whom less is known about 
optimal ICP treatment thresholds, but who have substantially lower ranges for ICP in health. 
It is still possible that lower thresholds for treating ICP should be considered for children, 
however these data to not clarify that threshold, and further study would be needed. What 















Why is the relationship between ICP and PbtO2 variable and what are the 
implications? 
There are several possible ways in which ICP and PbtO2 may interact. First, high ICP may 
directly cause low PbtO2 due to decreased CPP and/or tissue pressure effect. Second, a third 
factor may negatively affect both ICP and PbtO2 simultaneously. This does not preclude that 
the increase in ICP will in turn have a negative effect on PbtO2 after reaching a critically 
high level, but emphasizes that it is not the only factor causing a decrease in PbtO2.  Possible 
third factors include: 
1) Brain swelling: Tissue swelling is an important cause of raised ICP following TBI. 
Simultaneously oedema could cause an increase in the diffusion distance of oxygen from the 
capillary to the cell, thereby leading to a decrease in PbtO2.  
2) Hypotension: Poor cerebral perfusion brought on by systemic hypotension potentially 
leads to cerebral ischemia, cell swelling and tissue oedema, which may in turn result in an 
increase in ICP. Once again the increase in ICP accompanies a drop in PbtO2 but is not 
necessarily the direct cause thereof. 
3) Injury severity: Both raised ICP and low PbtO2 may reflect injury severity. The more 
injured the brain, the greater the perturbation in cerebral physiology. This is associated with 
not only a greater likelihood of ICP and oxygenation problems, but also a stronger 
probability of other complications, like impaired pressure autoregulation and vascular 
reactivity, poor cerebral perfusion and disturbed metabolic function. This combination of 
global injury could exercise further negative impact on ICP and PbtO2. 
Third, a factor may cause an increase in both ICP and PbtO2, such as hyperaemia, 
hypercarbia, and increased blood pressure when pressure autoregulation is impaired. 
Fourth, the factor affecting PbtO2 may have no association with ICP. The most overt of 
these are changes in blood pressure and systemic oxygenation (respiratory physiology and 
haemoglobin). However, some of these episodes of low PbtO2 occur even when blood 
pressure and systemic oxygenation appear to be adequate 
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, suggesting that other variables 
that are not commonly measured may also cause low PbtO2.  It follows that treating only 
ICP in order to ensure adequate tissue oxygenation, without actively monitoring some form 
of brain oxygenation may consequently leave some hypoxic insults untreated. 
Therefore, although treating ICP is likely to remain an important goal in TBI management, it 












greatest relevance to centres where no form of brain oxygenation is monitored. Given that 
episodes of low PbtO2 are independently associated with outcome in severe paediatric TBI, 
and perhaps even more strongly than ICP in certain circumstances, episodes of low PbtO2 in 
the absence of high ICP are likely to be clinically important. 
However, an interesting question arises regarding how to approach treatment of ICP, and in 
particular at what threshold, when PbtO2 is not compromised. Unnecessary treatment of ICP 
may have potentially adverse effects, while not treating ICP in the face of normal appearing 
PbtO2 may lead to delayed negative consequences if ICP were later to become uncontrolled. 
To exemplify, sustained hyperaemia may be associated with high ICP but adequate levels of 
PbtO2; if left untreated this may eventually lead to increased vasogenic oedema later in the 
patient’s course, and a more significant rise in ICP that would impair PbtO2. Currently 
recommended thresholds for ICP treatment are based on studies performed in the early 90’s 
and while these may still be relevant, it would be reasonable to re-examine these thresholds 
in the light of modern technology now being used to manage brain trauma. This would be of 
particular value in children for whom there is little evidence elucidating appropriate 
thresholds for ICP treatment given their unique and changing physiological profiles.  
Of course it must be borne in mind that PbtO2 is highly variable and represents oxygenation 
in a very focal area of the brain; consequently, there is some uncertainty about how well this 
can be extrapolated to other areas of the brain. However, there is some data to suggest that 
relative PbtO2 changes represent global changes in oxygenation when the PbtO2 catheter is 
placed in normal appearing brain in patients with diffuse injury where there are no focal 
contusions 
23, 113
. Additionally, while ICP may represent a more global cerebral phenomenon 
there may still be regional differences in the pressure gradients experienced. Therefore, 
although brain oxygenation monitors offer a focal measure, based on the fact that the PbtO2 
and ICP catheters are placed ipsilaterally in close proximity to each other it is likely that 
their measurements are reflecting the pressure and oxygenation status of the same tissue 
area.  
It is also important to recognise that cerebral pathophysiology is not static, but highly 
dynamic and variable, changing from one day to the next in a single patient, and displaying a 
very different picture from one patient to the next. Additional to ICP and PbtO2 there are 
several other variables that also have unique profiles and effects across time and individuals. 
Although the GEE attempted to account for inter-individual variation for both ICP, PbtO2 
and the other controlled variables, none of these variables stand alone, and it is their 












pathophysiological picture substantially, making it difficult to outline an average picture of 
cerebral pathophysiology in TBI. 
These findings suggest that PbtO2 reflects dynamics which are determined by several 
variables, not all of which can be easily measured. Strong associations were not found 
between PbtO2 and the other controlled variables. However, in individual patients it is also 
clear that variables such as PaO2, PaCO2, BP and Hb may affect PbtO2 dynamically, similar 
to the isolated changes in ICP seen in the case illustrations of this study. When analysing 
pooled data, this association may be lost. This may once again also be influenced by the fact 
that these patients were routinely treated for perturbations in any of these variables, such as 
hypotension, hypoxia, hypercarbia, and anaemia. CPP was found to correlate better with 
PbtO2 than ICP; since CPP is derived from both MAP and ICP, it has been suggested that it 
may better reflect the influence of MAP and ICP on PbtO2 
29
. Further study on CPP and 
brain oxygenation may better elucidate the nature of these relationships. 
 
Case Illustrations 
The trends selected in this section of the results illustrate the complexity of the relationship 
between ICP and PbtO2, but also how strongly increased ICP may reduce PbtO2 in specific 
circumstances. Positive relationships between ICP and PbtO2 are seen in conditions of 
hypercarbia, hyperaemia or impaired pressure autoregulation. However, even when ICP and 
PbtO2 increase in parallel, if ICP passes a particular threshold, it may begin to impede 
PbtO2. What this level may be is clearly not yet well understood, and it may indeed vary 
between individuals and over time.   
 
Data Capturing 
A comparison between electronic high frequency and hourly recordings of ICP and PbtO2 
suggests that over 93% of data points fell within a methodologically acceptable level of 
agreement. This is similar to findings by Zanier et al 
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who found that 96% of hourly and 
electronic data fell within the limits of agreement.  
While it appears as if electronic and hourly data may be used interchangeably with a certain 
degree of confidence, it is important to note that the electronic values analyzed for mean-
hour comparison were averaged over one hour. As the case illustrations suggest, significant 












minutes and can be camouflaged when averaged across time. The outliers seen in the graphs 
comparing electronic and hourly recordings are indicative of this phenomenon: large spikes 
or continuous fluctuations in either ICP or PbtO2 may go completely unnoticed when they 
occur off the hour, but significantly alter the electronic means which take them into account. 
This was reflected in the comparison of high ICP episodes in which hourly recording missed 
almost 15% of episodes captured digitally. The fact that these two recording techniques did 
not differ significantly in terms of episodes of PbtO2 < 20 mmHg may be due to the fact that 
unlike ICP which has a tendency to spike transiently, PbtO2 values fluctuate with less 
frequency and intensity, returning more gradually to baseline after a drop or rise.  
Although conducted with only a small sample, these results give indications about the 
respective capabilities of these two recording techniques. While manual hourly recording 
appears to provide a reasonably accurate account of physiological progress it may fall short 
of demonstrating insult severity. Electronic high frequency data may therefore be preferable 
in the assessment of cerebral variable profiles and would allow the investigation of 
pathological events, such as intracranial hypertension, in terms of time, frequency, depth and 
duration.  
While hourly data may miss some important relationships, analysis examining the 
relationship between ICP and PbtO2 in this study was conducted using time-linked readings, 
which were both recorded hourly and simultaneously. Therefore the association of ICP and 
PbtO2 holds true at those designated time points.  
 
Study Limitations 
There are several limitations of this study which should be considered. First, this cohort was 
composed of patients for whom ICP and PbtO2 were constantly being observed and 
managed and for whom the thresholds of ICP < 20 mmHg and PbtO2 > 20 mmHg were 
being targeted. Various interventions were employed which may have influenced these 
results, and untreated ICP and PbtO2 may demonstrate different relationships, particularly at 
higher values of ICP. PbtO2 and ICP values beyond the recommended thresholds occurred in 
relatively small proportions, for example, PbtO2 < 10 mmHg accounted for only 155 
observations from a total of 8389 observations. Different results may have been seen with 
untreated ICP and PbtO2, however, this could never be ethically justified. The fact that the 
analyses conducted on ICP and PbtO2 compared time-linked paired observations may 












reduced the relative proportions of high ICP and low PbtO2. Had terminal data not been 
removed from these analyses the relationship between ICP and PbtO2 may have appeared 
stronger, however, this is a study conducted on children that were well enough to treat, the 
results of which may be of relevance to patients being treated in the usual clinical context. 
Second, although age was considered in 3 ‘bands’, the rapidly changing physiological 
profiles exhibited by a paediatric population make the accurate evaluation of ICP very 
challenging. Also, very little data was available to guide the selection of which thresholds 
were appropriate for these age bands. Optimal treatment thresholds for different age groups 
are still not known, and it is possible that better identification of specific ICP thresholds for 
each age may improve the analysis. Additionally, although open sutures or fontanels in 
younger children could potentially create a different picture of intracranial dynamics, 
children under the age of 2 years were included in the overall correlation analysis. This was 
based on the fact that in general this cohort was composed of a very large age range of 
children (4 months – 14 years), all of whom may differ from each other in anatomic and 
physiological characteristics across the age spectrum. The correlation was however repeated 
using only patients over the age of 2 years, but this did not improve the demonstration of a 
relationship between PbtO2 and ICP (r = 0.045, p < 0.01) The scatter plot is included in 
Appendix B. While study of smaller age bands would provide valuable information this 
would require a very large number of patients per age category and would be specific to 
narrower patient groups. This cohort represents the heterogeneous composition of patients 
that would be seen in the context of paediatric TBI and allows for some generalizability of 
results to this patient population as a whole and who are treated according to standard 
guidelines regardless of age. This study is also a first step in identifying potential issues 
which can guide further studies on more defined and homogenous patient groups. 
Third, while all values of PbtO2 and ICP were time-linked and therefore comparable, use of 
hourly data may have been limited. Analysis of data from individual patients with high-
frequency data collection did however reveal several different clinical scenarios depicting 
varying relationships between ICP and PbtO2. ROC’s constructed in individual patients with 
these high frequency data points also suggest that in some cases ICP and PbtO2 have 
stronger relationships, while in others this relationship is weak. 
Finally, no monitoring modality is without its limitations or presents the full picture. 
Although PbtO2 appears to be a useful tool for monitoring an aspect of brain oxygenation, it 
is still not a precise measure of the adequacy of brain oxygenation. In particular it is sensitive 












jugular venous saturation and near-infrared spectroscopy may produce different results but 
this is thought to be unlikely. PET is the gold standard for measuring brain perfusion, but can 
only be done as a ‘snapshot’ study at one point in time. Transcranial Doppler (TCD) 
produces data on velocity from vessels of the Circle of Willis and approximates changes in 
CBF relatively well. However, it is very difficult to perform TCD continuously in a reliable 
manner. Local CBF measurement, for example with a thermal diffusion probe, may provide 
some further insights on this topic. Still, very little data exists on the relationship between 
ICP and measures of brain oxygenation, particularly for children; therefore these data are 
useful to inform further study on the subject. Furthermore, although ICP was used as a 
surrogate of cerebral venous pressure (CVP), ICP and CVP have been shown to exhibit a 
good correlation, and considering the challenge involved in measuring CVP directly, ICP is 
widely used as an acceptable indicator of CVP in perfusion assessment. 
It should also be mentioned that although the mechanism of injury in non-accidental injury 
(NAI) is unique and may potentially create a different pathophysiological picture, the two 
cases of NAI were included in analysis for the following reasons; firstly; while it is possible 
that the pathophysiology of TBI may differ based on the mechanism of injury, our cohort 
was heterogeneous in the manner by which they were injured, as is usually the case for TBI 
studies. Arguably, there are several mechanisms of injury that may produce unique patterns 
of pathophysiological disturbances. Therefore, if the mechanism of injury were to be taken 
into account in our analysis, this would require subdividing our patient cohort into several 
categories of injury beyond merely NAI. As much as it is true that this analysis would 
produce a more accurate result; this would require a very large number of patients per 
category, which is difficult to achieve in a single centre study.  Secondly, current treatment 
guidelines are standard regardless of mechanism of injury with the underlying assumption 
that pathophysiological principles are the same across all TBI patients. While this may not be 
entirely appropriate it is the framework within which patients are being managed, and the 
results of this analysis are intended to be of value to the entire treating population. Thirdly, 
while ICP and PbtO2 certainly exhibit a relationship this relationship may demonstrate 
variability; mechanism of injury may be a factor to contributing to this, however it is also 
only one of many.   
 
Future Research 
The results of this study strongly suggest the need for more research directed at 












relates to global brain damage in the context of paediatric TBI. This would enable better 
prediction of how PbtO2 will be affected by intracranial and systemic pathophysiological 
changes, would provide greater insight into the nature of the interaction between PbtO2 and 
other relevant variables, would allow better precision of critical threshold points that can be 
tolerated and that should indicate treatment and would assist in targeting treatment more 
appropriately. These are important to improve the use of ICP monitoring, which is widely 
practiced. Specifically, further study is required on optimal ICP thresholds in children. 
Retrospective examination of ICP patterns in children who die may only reflect ICP in the 
terminal phase of the patient’s clinical course, or the confounding association of mortality 
and high ICP with increased severity of disease, rather than the adverse effect ICP itself has 
on causing neurological compromise or death. If age is to be taken into account, this requires 
large numbers of patients. Given the relatively small numbers of children with severe TBI 
seen at individual centres, this would require a multicentre study.  Similar study would have 
to be done for thresholds of MAP/ CPP with age. Comparison of similar data derived from a 
study of adult patients may be useful to detect differences in the relationship between various 
















This study demonstrates that the relationship between ICP and PbtO2 is complex. While ICP 
does negatively affect brain oxygenation, several other factors may also be important in 
individual patients and at different times. Consequently, optimal approaches to ensuring the 
adequacy of brain oxygenation should take into consideration not only ICP, but a 
complement of relevant variables, and should ideally include some form of brain oxygen or 
perfusion monitoring. Further research into understanding other significant factors that 
influence PbtO2 and mediate the relationship between ICP and PbtO2 would be of great 
value in informing treatment strategies directed at avoiding secondary cerebral 
ischemia/hypoxia with the hope of improving outcome after TBI in children. In addition, 
more investigation into optimising ICP thresholds for treatment in children is needed. The 
use of complimentary monitoring modalities may assist in this task. Depending on the 
adequacy of measures of brain perfusion, metabolism or oxygenation, it is possible that 
targeting a range of ICP values in individual patients may be appropriate; however this 













 APPENDIX A: PATIENT MANAGEMENT 
 
General 
Management of ICP and CPP at Red Cross Children’s War Memorial Hospital is broadly in 
keeping with the Guidelines for the Acute Medical Management of Severe Traumatic Brain 
Injury in Infants, Children, and Adolescents 
2
. Significant intracranial haematomas were 
surgically evacuated as soon as possible, ICU treatment aimed to avoid systemic hypoxia 
and hypotension, and ICP, CPP, and PbtO2 were actively managed. Baseline patient 
management involved analgesia (morphine), sedation (midazolam and/or diazepam), 
elevation of the head of the bed to 15 to 20°, maintenance of rectal temperature between 36 
and 37°Celsius, and maintenance of serum sodium ≥ 140 mmol/L. 
ICP management 
ICP was measured with an intraparenchymal monitor (Codman ICP Express [Codman, 
Raynham, MA] or Camino [Integra Neurosciences, Plainsboro, NJ]) or a ventriculostomy 
device. Sustained ICP > 20mmHg was treated actively. In the case of intracranial 
hypertension, head CT scanning was performed to rule out delayed development of 
intracranial haematomas or hydrocephalus. The management protocol for elevated ICP was 
influenced by the underlying pathophysiology, and where possible took into account 
concurrent PbtO2, PaCO2, CPP, TCD flow velocities and status of pressure autoregulation. 
When ICP was elevated despite these baseline measures, increased sedation, neuromuscular 
blockade, ventriculostomy, controlled moderate hyperventilation, and/or hyperosmolar 
therapy (5% saline and/or mannitol) were employed in a stepwise fashion.  
Controlled moderate hyperventilation (PaCO2 28 to 30mmHg) was infrequently used and 
only for brief periods as a second-tier therapy to treat intracranial hypertension. It was used 
in conjunction with transcranial Doppler (TCD) and PbtO2 measurements, and only if PbtO2 
was greater than 20mmHg. Hypertonic saline was used to treat elevated ICP if the serum 
sodium was < 155 mmol/L. Thiopentone was used for elevated ICP refractory to standard 
treatment on condition that the patient’s blood pressure (BP) was stable. Decompressive 
craniectomy was used as a second-tier therapy in cases of refractory elevated ICP which did 
not respond to thiopentone or for rapidly deteriorating ICP control where ICP increased to ≥ 












was used as an emergency when patients were admitted with gross brain oedema and 
increased ICP with signs of cerebral herniation. 
CPP Management 
Management of CPP was based broadly on the paediatric guidelines 
5 
which recommend 
maintaining CPP > 50mmHg, while taking into account that CPP may vary based on patient 
age. A more conservative approach was used for children < 2 years old for whom CPP of 45 
mmHg was tolerated if PbtO2 was > 20mmHg. In general, CPP management was influenced 
by the concurrent ICP and PbtO2 values, as well as TCD and autoregulation testing results 
when available.  The first step in CPP management involved ensuring the patient was 
euvolaemic; if not, intravenous isotonic crystalloids were infused until an adequate volume 
status was obtained. Volume status was assessed by clinical examination, urine output, heart 
rate, central venous pressure and BP. If the patient was euvolaemic, MAP was elevated by 
administering noradrenalin or dopamine. 
PbtO2 Management 
PbtO2 was measured with Licox catheters (Integra Neurosciences, Plainsboro, NJ), which 
were inserted into normal-appearing right frontal white matter if there were no localised 
lesions. Occasionally a second PbtO2 monitor was placed in a pericontusional location if the 
patient had what appeared to be a clinically significant large contusion (these data were 
excluded from analysis). Monitor location was confirmed on follow-up head CT. 
Compromised (low) PbtO2 was defined as <20 mmHg and was treated using a hierarchical 
treatment algorithm, which depended on the depth and duration of the reduction in PbtO2, 
and in which the cause of low PbtO2 was always sought and treated where possible. In the 
absence of detecting a specific cause the following measures were used depending on ICP, 
MAP, PaO2, Hb, PaCO2, TCD flow velocities and the status of autoregulation, when 
known: 1) elevated or borderline ICP was treated more aggressively if present, 2) the 
patients BP was elevated to test PbtO2 at a higher CPP using volume infusion and/or 
inotropic support unless impaired autoregulation caused increases in ICP simultaneous with 
elevated BP, 3) higher PaCO2 was tolerated to induce cerebral vasodilation if ICP was not 
elevated, 4) blood was transfused to increase Hb to ≥ 10 g/dl, and 5) the inspired fraction of 
oxygen (FiO2) was increased as an emergency temporary measure or if PbtO2 remained low 
despite treating the above mentioned parameters. Where possible management aimed at 














Patients remained intubated and ventilated for the duration of intracranial monitoring. 
Ventilation was adjusted to maintain SaO2 > 95% and PaO2 approximately 13kPa 

















APPENDIX B: CORRELATION ANALYSIS EXCLUDING DATA 
FROM CHILDREN UNDER THE AGE OF 2 YEARS 
 
Having excluded all data for patients under the age of 2 years, Spearman’s correlation was 
once again performed on the remaining ICP and PbtO2 data (6795 observations). The results 
of this analysis demonstrated that excluding the data on these children did not improve the 
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